EurekaMag PDF full texts Chapter 36,032

Brisson, M.; Edmunds, W.J.; Gay, N.J. 2003: Varicella vaccination Impact of vaccine efficacy on the epidemiology of VZV. Journal Of Medical Virology. 70(supplement 1): S31-S37

Black, S. 2000: Varicella vaccination: to test or not to test. American Journal of Medicine 108(9): 746-747

Brisson, M.; Edmunds, W.John.; Gay, N.J.; Miller, E. 2002: Varicella vaccine and shingles. JAMA 287(17): 2211; Author Reply 2211-2

Jackowska, T.; Lukowska, K.; Loch, T.; Gorska, E.; Pacholska, J.; Popko, K.; Rokicka Milewska, R. 2004: Varicella vaccine in children with acute lymphoblastic leukemia and their siblings. Annals of Hematology 83(Suppl 1): S23

Mehta, J. 2002: Varicella vaccine in recipients of hematopoietic-cell transplants. New England Journal of Medicine 347(20): 1624-1625; Author Reply 1624-1625

Rosenthal, J.; Mccauley, M.; Morita, J.; Brink, E.; Diaz, P.; Rodewald, L. 2002: Varicella vaccine under-used among African-American children in Chicago. Pediatric Research 51(4 Part 2): 166A

Davies, N.W.S.; Sewell, C.; Morris, P.; Mumford, C.J.; Clarke, C.; Thompson, E.J.; Giovannoni, G. 2002: Varicella zoster encephalitis in two immunocompetent adults mimicking variant Creutzfeld Jacob Disease. Journal of Neurovirology 8(Suppl 1): 97-98

Tarawah, Ahmad; Al Hajjar, Sami; Belgaumi, Asim F.; Al Mohsen, Ibrahim; Al Mahr, Mohammad; Al Jefri, Abdullah; Al Musa, Abdul Rahman; Saleh, Mahasen; Osman, Layla; Osman, Mohammed; Salim, Mohammed F.; El Solh, Hassan 2002: Varicella zoster infection in children with acute lymphoblastic leukemia. Pediatric Research 51(4 Part 2): 235A

Chen, J.J.; Zhu, Z.; Gershon, A.A.; Gershon, M.D. 2002: Varicella zoster virus Mannose 6-phosphate receptors, enteric neurons, and latent infection. FASEB Journal 16(4): A201

Annunziato, P.W.; Ampofo, K.K. 2001: Varicella zoster virus cell mediated immunity in HIV-infected children and adolescents on highly affective antiretroviral therapy. Pediatric Research 49(4 Part 2): 254A

Crowley, B. 2001: Varicella zoster virus immunization in pregnancy. Journal of Hospital Infection 49(2): 154

Eickmann, M.; Gicklhorn, D.; Radsak, K.; Hauser, H.P.; Giesendorf, B. 2001: Varicella zoster virus immunoreactive protein VP26 and its diagnostic use. Official Gazette of the United States Patent and Trademark Office Patents 1248(2)

Moffat, J.F.; Taylor, S.L.; Leisenfelder, S.; Kinchington, P.R. 2003: Varicella zoster virus infection induces cyclin dependent kinase 2/cyclin E expression and replication is blocked by roscovitine, a cdk2 inhibitor. Antiviral Research 57(3): A68

Vázquez, M. 2004: Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine. Current Opinion in Pediatrics 16(1): 80-84

Gilden, D.H. 2002: Varicella zoster virus vasculopathy and disseminated encephalomyelitis. Journal of the Neurological Sciences 195(2): 99-101

Chee, Y.; Dees, C.; Watson, H.G. 1999: Varicella zoster virus-induced bilateral acute retinal necrosis syndrome post-fludarabine in Waldenstroms macroglobulinaemia. British Journal of Haematology 105(Suppl 1): 90

Dekonenko, Y.P. 2002: Varicella zoster-induced diseases Clinical manifestations, incidence, and treatment. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 4: 41-44

Thami, G.P.; Kaur, S. 2003: Varicella, herpes zoster and dissemination. Pediatric Infectious Disease Journal 22(3): 295-296

Mitchell, B.M.; Font, R.L. 2000: Varicella-Zoster DNA is detectable in the temporal arteries of some patients with Giant Cell Arteritis. IOVS Investigative Ophthalmology and Visual Science 41(4): S59

Kennedy, P.G.E. 2003: Varicella-Zoster virus Neurological complications and latency. European Journal of Neurology 10(Suppl 1): 210

Katz, B.Z.; Salimi, B.; Neuman, M.; Connelly, B.L.; Myers, M.G. 1999: Varicella-Zoster virus does not encode a complete herpes simplex virus glycoprotein D homologue. Pediatric Research 45(4 Part 2): 165A

Lungu, O.; Annunziato, P.W. 1999: Varicella-zoster virus: latency and reactivation. Contributions to Microbiology 3: 61-75

Arvin, A.M. 2001: Varicella-zoster virus: molecular virology and virus-host interactions. Current Opinion in Microbiology 4(4): 442-449

Vafai, A. 2001: Varicella-zoster virus antigen. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Abendroth, A.; Arvin, A. 1999: Varicella-zoster virus immune evasion. Immunological Reviews 168: 143-156

Kennedy, P.G.E. 2002: Varicella-zoster virus latency in human ganglia. Reviews in Medical Virology 12(5): 327-334

Ku, C.C.; Zerboni, L.; Ito, H.; Arvin, A. 2003: Varicella-zoster virus pathogenesis Viral transfer to skin in CD4+ T lymphocytes and evasion of IFN-alpha. FASEB Journal 17(7): C154

Cattaneo Pangrazzi, R.M.C.; Dubey, R.K.; Imthurn, B.; Sigg, C.; Bannwart, F.; Keller, P.J.; Rosseli, M. 2001: Varicocele and atrophy with elevated FSH is associated with increased apoptosis in human testis. Human Reproduction 16(Abstract Book 1): 63-64

Anis, M.T.; Mostafa, T.; El Nashar, A.; Imam, H.; Othman, I.A. 2001: Varicocele elevates reactive oxygen species levels and reduces antioxidant activity of internal spermatic vein blood of infertile men with varicocele. Journal of Andrology (Suppl): 108

Kunnen, M.F.; Verbaeys, A.C.R.; Kunnen, J.J. 1999: Varicocele embolization with tissue adhesive Results in 2102 consecutive patients. Journal of Urology 161(4 Suppl): 347

Lipshultz, L.I.; Leibman, B.; Grinblat, D.M.; Kim, E.D. 1999: Varicocele repair improves semen parameters in azoospermic mean with testicular failure. Journal of Urology 161(4 Suppl): 312

Pasqualotto, F.F.; Lucon, A.M.; Hallak, J.; Saldanha, L.B.; Goes, P.M.; Colombo, J.R.; Arap, S. 2001: Varicocele repair improves semen parameters in azoospermic men with testicular failure irrespective of testicular histology. Journal of Andrology (Suppl): 112

Paduch, D.A.; Davol, P.; Fuchs, E.F.; Niedzielski, J. 2002: Varicocele repair in adolescents Are we preserving fertility?. Journal of Urology 167(4 Suppl): 311

Onel, E.; Kwak, S.; Niederberger, C.S.; Ross, L.S. 1999: Varicocele surgery improves sperm-egg penetration as demonstrated by sperm pentration assay. Journal of Urology 161(4 Suppl): 312

Minucci, S.; Mazzoni, G.; Gentile, V. 2001: Varicocele treatment Evolution in sclerosing techniques. Journal of Andrology (Suppl): 111

Sheynkin, Y.; Schulsinger, D. 2003: Varicocelectomy From antiquity to fertility. Journal of Urology 169(4 Suppl): 253-254

Serafetinides, E.; Argyropoulos, V.; Zarogiannos, A.; Tsakiris, P.; Arhontakis, A. 2003: Varicocelectomy in patients with normal semen analysis. European Urology Suppls 2(1): 120

Androulakis, A.E.; Katsaros, A.A.; Kartalis, A.N.; Triantafyllidi, E.D.; Pantazis, A.A.; Stougiannos, P.N.; Toutouzas, P.K.; Kallikazaros, I. 2002: Varicose veins are common in patients with coronary artery ectasia Just a coincidence or a generalized defect of the vessel wall?. Circulation 106(19): 2; 679

Oliver, G.R. 2002: Varied approaches to green chemistry in modern agriculture. Abstracts of Papers American Chemical Society 223(1-2)

Du, L.; Forbes, M. 2000: Varied correlation in glaucoma between parameters of scanning laser polarimetry with optic disc morphology under fundoscopy, Humphrey visual field test and Goldmann visual field test. IOVS Investigative Ophthalmology and Visual Science 41(4): S92

Thorlacius, S.; Olafsdottir, G.H.; Tryggvadottir, L.; Tulinius, H.; Eyfjord, J.E. 1999: Varied effects of a BRCA2 founder mutation. American Journal of Human Genetics 65(4): A327

Peden Adams, M.M.; Adams, C.; Meyers, K.; Eudaly, A.; Smythe, J.; Eudaly, J.; Keil, D.E. 2003: Varied exposure regimes to methyl mercury during postnatal development leads to different immune responses. Toxicological Sciences 72(S-1): 376

Stoner, J.D.; Clanton, T.L.; Angelos, M.G. 2004: Varied oxygen delivery at reperfusion modifies reactive oxygen species generation in the isolated perfused rat heart. Biophysical Journal 86(1): 208a

Cserhalmi Friedman, P.B.; Frank, J.; Wolff, C.; Christiano, A.M. 1999: Variegate porphyria in South America Identification of a novel founder mutation in Chilean patients and its future implications. Journal of Investigative Dermatology 112(4): 539

Ferrer, M.D.; Tauler, P.; Sureda, A.; Palacín, C.; Tur, J.A.; Pons, A. 2010: Variegate porphyria induces plasma and neutrophil oxidative stress: effects of dietary supplementation with vitamins E and C. British Journal of Nutrition 103(1): 69-76

Markland, W.; Ladner, R.C.arles 2002: Variegated Kunitz domain peptide library and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1260(4)

Rajvikraman, R.; Thomas, J.; Pandurangan, A.G. 2001: Variegated Philippine violet A new ornamental plant. Journal of Economic and Taxonomic Botany 24(3): 723-726

Adams, D.; Morris, B. 2000: Variegated control of the renin promoter. Journal of Hypertension 18(Suppl 4): S183

Tamura, T.; Takechi, K.; Murata, M.; Sakamoto, W. 2001: Variegation in the var1-1 mutant is caused by a frame-shift mutation in an FtsH-like gene. Plant and Cell Physiology 42(Suppl): s48

Tamura, T.; Takechi, K.; Sakamoto, W.; Murata, M. 2000: Variegation in the var1-1 mutant is likely caused by a frame-shift mutation in an FtsH-like gene. Genes and Genetic Systems 75(6): 367

Hilaire,C.; Ruesch,J. 2010: Varietal creation in peach constant and brisk activity. Infos Ctifl: 8, 9-12

Hirai,Y.; Numa,K.; Nakai,K.; Tsuda,M. 2010: Varietal difference in the cost of dark respiration for panicle growth and carbohydrate mobilization. Japanese Journal Of Crop Science: 1, 53-61

Okamoto, G.; Doi, C.; Hirano, K. 1999: Varietal difference in the occurrence of abnormal swelling of grape rachises. American Journal of Enology and Viticulture 50(3): 369

Benitez,E.R.; Khan,N.A.; Matsumura,H.; Abe,J.; Takahashi,R. 2010: Varietal differences and morphology of cleistogamy in soybean. Crop Science: 1, 185-190

Hirasawa,T.; Ozawa,S.; Taylaran,R.D.; Ookawa,T. 2010: Varietal differences in photosynthetic rates in rice plants, with special reference to the nitrogen content of leaves. Plant Production Science: 1, 53-57

Witt, F.; Wydra, K.; Mavridis, A.; Rudolph, K. 2001: Varietal resistance against Xanthomnas campestris pv manihotis, the causal agent of the Cassava Bacterial Blight. Phytopathology 91(6 Suppl): S96

Johnston, S.A.; Kline, W.L.; Fogg, M.L.; Zimmerman, M.D. 2002: Varietal resistance evaluation for control of Phytophthora blight of pepper. Phytopathology 92(6 Suppl): S40

Shete, M.B.; Pawar, B.G.; Karale, A.R.; Kaulgud, S.N. 1999: Varietal response of Aonla for patch budding. Journal of Maharashtra Agricultural Universities 24(2): 210

Lee, Y.S.; Kang, C.S.; Lee, Y.S.; Kim, Y.H. 2001: Varietal variations in bran tocopherol and tocotrienol contents of rice plants. HortScience 36(3): 556

White, D.B. 1999: Varieties of Poa annua. Official Gazette of the United States Patent and Trademark Office Patents 1223(3)

Kessels, R.P.; de Haan, E.H.; Kappelle, L.J.; Postma, A. 2001: Varieties of human spatial memory: a meta-analysis on the effects of hippocampal lesions. Brain Research. Brain Research Reviews 35(3): 295-303

Lumry, R. 2000: Varieties of knots and hinges-The machinery of catalysis. Biophysical Journal 78(1 Part 2): 156A

Peterson, M.A.; Zemel, R.A. 2000: Varieties of location specificity in object learning. IOVS Investigative Ophthalmology and Visual Science 41(4): S328

Peretz, I.; Champod, A.S.; Hyde, K. 2003: Varieties of musical disorders. the Montreal Battery of Evaluation of Amusia. Annals of the new York Academy of Sciences 999: 58-75

Kertesz, A.; Davidson, W.; Mccabe, P. 2001: Varieties of primary progressive aphasia. Neurology 56(8 Suppl 3): A178

Earley, J.E. 2003: Varieties of properties: an alternative distinction among qualities. Annals of the new York Academy of Sciences 988: 80-89

Gazula, A.; French, D.G.; Kleinhenz, M.D.; Scheerens, J.C. 2003: Variety and shading effects on pigment levels in lettuce grown under contrasting temperature regimens. HortScience 38(5): 692

Yoshida, W.; Kato, C.; Ishida, S. 2000: Variety and universality of the genus Dugesia of Japan studied by comparisons of partial 18S rDNA. Zoological Science 17: 41

Mccracken, K.J.; Mcnab, J.M. 2000: Variety differences and impact of IB/IR rye gene on nutritive value of wheat for broilers. British Poultry Science 41(5): 695-696

Mccracken, K.J. 2001: Variety differences of impact of IBIR rye translocation on ileal digestibility of nutrients in broiler diets containing high levels of wheat. British Poultry Science 42(Suppl): S93-S94

Tantasawat,P.; Trongchuen,J.; Prajongjai,T.; Seehalak,W.; Jittayasothorn,Y. 2010: Variety identification and comparative analysis of genetic diversity in yardlong bean using morphological characters, SSR and ISSR analysis. Scientia Horticulturae 4(2): 204-216

Foote, J.; Murphy, S.; White, K.; Wilkens, L.; Basiotis, P.; Carlson, A. 2004: Variety in the diet is not equal to counting foods. American Journal of Epidemiology 159(11, Suppl S): S56

Tanaka, E.; Matsumoto, K.; Yokosawa, H.; Sawada, H. 2000: Variety in the vitelline coat component VC70 of the ascidian Halocynthia roretzi. Zoological Science 17: 64

Morita, T.; Bu, Y. 2000: Variety of Stevia Rebaudiana Bertoni. Official Gazette of the United States Patent and Trademark Office Patents 1235(4)

Sutthirangkun, L.; Sukchotiratana, M. 2003: Variety of soybean on the quality of Thai fermented soybean Thua-Nao inoculate with Bacillus subtilis. FEMS Congress of European Microbiologists Abstract Book 1: 127

Mueller Steinhardt, M.; Fricke, L.; Kirchner, H.; Haertel, C. 2003: Various IL-6 promoter polymorphisms are linked to transplant outcome. Genes and Immunity 4(Suppl 1): S10

Mikhailuk, T.; Darienko, T.; Kondratyuk, S.; Kostikov, I.; Demchenko, E. 2001: Various algal groups from granitic outcrops in the steppe region of the Ukraine. Phycologia 40(4 Suppl): 111

Motegi, H.; Hoshino, E.; Tatewaki, M.; Suzuki, D.; Ohbayashi, T.; Ohse, T.; Sato, T.; Adachi, M.; Okinaga, K.; Imamura, T.; Shiga, J.; Kimura, M. 2000: Various autoimmune abnormalities in a patient with Crohns disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1360

Nakamura, F.; Tanaka, M.; Matsumura, A.; Mizokawa, S.; Nozaki, S.; Kawabata, A.; Yamaguti, K.; Kuratsune, H.; Watanabe, Y. 2003: Various biological factors related to fatigue and its recovery by modified forced swim. Neuroscience Research Suppl (26): S85

Kishida, A.; Fujisato, T.; Funamoto, S.; Nishikoka, H.; Yoshida, K.; Kamata, W.; Yamahigashi, N.; Suga, M.; Kimura, T.; Miyazaki, K.; Niwaya, K.; Nakatani, T.; Kitamura, S. 2003: Various decellularized tissues for tissue engineering scaffold prepared by new technology. International Journal of Artificial Organs 26(9): 864

Albrecht, D.; Nitschke, T.; Von Bohlen Und Halbach, O. 2000: Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats. FASEB Journal 14(7): 925-931

Tsioufis, K.; Toutouza, M.; Stefanadis, C.; Papanikolas, I.; Kallikazaros, I.; Toutouzas, K.; Tzioumis, K.; Pitsavos, C.; Katte, K.; Toutouzas, P. 2001: Various effects of newer risk factors on circadian blood pressure variations in untreated essential hypertensive subjects. European Heart Journal 22(Abstract Suppl): 610

Stenman, U.H. 2000: Various forms of PSA in the diagnosis of prostate cancer. Tumor Biology 21(Suppl 1): 21

Schwartz, J.L.; Gu, X. 2002: Various forms of vitamin E alter the induction of apoptosis in normal, transformed, and malignant oral keratinocytes. Proceedings of the American Association for Cancer Research Annual Meeting 43: 478

Eisenberg, I.; Grabov Nardini, G.; Hochner, H.; Potikha, T.; Askanas, V.; Bertorini, T.; Bradley, W.; Karpati, G.; Merlini, L.; Sadeh, M.; Argov, Z.; Mitrani Rosenbaum, S. 2002: Various forms of worldwide quadriceps sparing myopathy are caused by mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene. European Journal of Human Genetics 10(Suppl 1): 259

Winterhagen, P.; Voemel, M.; Schachtner, J. 2002: Various guanylyl cyclases might be involved in cGMP regulation in the developing antennal lobe of the sphinx moth Manduca sexta. Zoology (Jena) 105(Suppl 5): 47

Li, H.; Zhang, Z.; Kolls, J.K.; Noel, R.A. 2000: Various inflammatory stimuli induce interleukin-6 and interleukin-8 production in human intestinal epithelial cells. JPGN 31(Suppl 2): S82

Staudt, S.; Bellmann, C.; Schuett, F.; Loesch, A.; Holz, F.G. 2000: Various intra- and extracellular fluorophores other than RPE lipofuscin contribute to variations in spatial distribution and intensity in topographic fundus autofluorescence images. IOVS Investigative Ophthalmology and Visual Science 41(4): S168

Skardova, I.; Ojeda, F.; Levkut, M. 1999: Various kinds of immunosuppressive factors that induce apoptosis in bursal B and T lymphocytes in chickens. Scanning 21(2): 104-105

Simic, D.V.; Mimic Oka, J.; Simic, T.; Ille, K.; Dragicevic, P. 2000: Various lines of antioxidant defense in patients with different stages of essential hypertension. Nephrology Dialysis Transplantation 15(9): A73

Fukuchi, T.; Nakatsue, T.; Suda, K.; Ueda, J.; Tanaka, Y.; Funaki, S.; Ohta, A.; Hara, H.; Shirakashi, M.; Abe, H. 2001: Various mechanisms related with angle closure glaucoma in nanophthalmos. IOVS Investigative Ophthalmology and Visual Science 42(4): S420

Enkiri, F. 2003: Various methods for the assessment of biofilms on construction products in contact with drinking water. Journal Europeen d'Hydrologie 34(1): 69-81

Denis, F.; Venot, C.; Rogez, S. 1999: Various modes of viral transmission from mother to fetus. Archives de Pediatrie 6(Suppl 2): 406s-408s

Kelley, H.J.; Jones, L.A.; Salgaller, M.L. 2000: Various molecules associated with antigen processing and presentation are not decreased in the peripheral blood mononuclear cells and tumor infiltrating lymphocytes of prostate cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 41: 876

Hotta, Y.; Nakamura, M.; Nomura, R.; Miyake, Y. 2000: Various mutations of XLRS1 gene cause juvenile retinoschisis with fundus albipunctatus-like lesions. IOVS Investigative Ophthalmology and Visual Science 41(4): S885

Pichkhadze, B.; Shanshiashvili, L.; Mikeladze, D. 2001: Various peptide fragments of Mbp generate different effects on production of nitric oxide in glial cells and their viability. Journal of Neurochemistry 78(Suppl 1): 44

Pantelic, L.; Juranic, Z.; Stanojkovic, T.; Manic, S.; Radulovic, S.; Joksimovic, J.; Juranic, I. 1999: Various ph of nutrient medium changed the extent of spermine-FBS mediated cytotoxic effect on three neoplastic cell lines. European Journal of Cancer 35(Suppl 4): S198

Watanabe, K. 2000: Various physiological functions of ovomucin on the specific structure. Nippon Nogeikagaku Kaishi 74(7): 802-806

Karatapanis, S.; Georgopoulos, S.; Ketikoglou, I.; Natsios, A.; Papamarkos, D.; Papakonstantinou, L.; Damala, D.; Petsa, I.; Artikis, V. 2000: Various plasma proteins level in the assessment of liver synthetic function. Journal of Hepatology 32(Suppl 2): 159

Meulenberg, E.P.; Wieland, W.H.; Peelen, G.O.H. 2000: Various production methods for antibodies against pesticides. Abstracts of Papers American Chemical Society 219(1-2): AGRO 123

Kwiatkowski, M.; Recker, F.; Piironen, T.; Petersson, K.; Luemmen, G.; Huber, A.; Tscholl, R. 1999: Various ratios of human glandular kallikrein to free and total PSA improve discrmination between G1-G2 and G3 prostate tumors. Journal of Urology 161(4 Suppl): 239

Fujimoto, Y.; Komiyama, N.; Nishiyama, S.I.; Nakanishi, S.; Momomura, S.I. 1999: Various responses of vessel remodeling in a saphenous vein graft after coronary artery bypass grafting demonstrated by intravascular ultrasound. Journal of the American College of Cardiology 33(2 Suppl A): 19A

Tam, B.M.; Moritz, O.L.; Hurd, L.B.; Deretic, D.; Papermaster, D.S. 1999: Various rhodopsin peptide sequences fused to GFP distribute differently in rods of transgenic Xenopus laevis retinas. IOVS Investigative Ophthalmology and Visual Science 40(4): S212

Kubes, M.; Gajdosova, E.; Mucha, V.; Kovacova, E.; Toman, R. 2000: Various strains of Coxiella burnetii and their lipopolysaccharides induce a tumor necrosis factor alpha in murine macrophages from BALB/c and C3H/HeJ mice in different manner. Journal of Endotoxin Research 6(2): 167

Fisher, J.D.; Tice, C.M. 1999: Various synergistic herbicidal compositions. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1563

Pearson, D.C.; Richardson, K.T. 2003: Various thiol complexes, processes for their synthesis and clinical applications. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Chang, J.C.; Kathula, S.K. 2001: Various thrombotic microangiopathic syndromes in patients with thrombotic microangiopathy. Blood 98(11 Part 2): 58b-59b

Suh, K.S.; Lee, K.W.; Roh, H.R.; Lee, M.K.; Koh, Y.T.; Lee, K.U. 2001: Various types of donor hepatectomy according to the required graft volume in adult living donor liver transplantation. TransplantationProceedings 33(1-2): 1410

Kamisago, M.; Hirayama Yamada, K.; Imamura, S.I.; Aotsuka, H.; Higaki, T.; Horigome, H.; Maeda, J.; Shimizu, H.; Ando, M.; Takao, A.; Momma, K.; Nakazawa, M.; Matsuoka, R. 2003: Various types of hypertrophic cardiomyopathy caused by PTPN11 missense mutations. Circulation 108(17): IV264

Stepanchenko, A.V.; Grechko, V.E.; Sharov, M.N.; Grigoryan, Y.A.; Kornienko, A.M.; Neymatov, E.M. 2000: Various types of in-patient treatment of exacerbations of trifacial neuralgia. European Journal of Neurology 7(Suppl 3): 124

Cetta, F.; Montalto, G.; Santoro, G.; Gori, M.; Zuckermann, M.; Boldrini, R.; Bosman, C.; Tomlison, G. 2000: Various types of primary liver tumors occur in patients with germ-line mutations of the APC gene. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1383

Nakayama, J.; Watanabe, A.; Nagano, A.; Koga, T.; Tsukamoto, K.; Shimada, S. 1999: Various vitamin D3 analogues can inhibit growth of human melanocytes in vitro. Pigment Cell Research (Suppl 7): 59

Cakmak, I.; Aydin, L.; Gulegen, E.; Wells, H. 2003: Varroa and tracheal mite incidence in the Republic of Turkey. Journal of Apicultural Research 42(4): 57-60

Santillan Galicia, M.T.; Otero Colina, G.; Romero Vera, C.; Cibrian Tovar, J. 2002: Varroa destructor infestation in queen, worker, and drone brood of Apis mellifera. Canadian Entomologist 134(3): 381-390

Steinert, M.; Wobus, M.; Schuetz, A.; Hamann, J.; Eichfeld, U.; Aust, G. 2001: Varying CD97 expression in lung carcinomas and tumour cell lines. European Journal of Cancer 37(Suppl 6): S45-S46

Osman, H.; Shanmuganayagam, D.; Wiebe, D.; Folts, J. 2000: Varying antiplatelet/antioxidant properties of flavonoid plant extracts. FASEB Journal 14(4): A660

Baker, D.N.; Scheiber, P.; Quinn, W.J. 2002: Varying bacterial concentrations to affect transformation rate success. Plant Biology (Rockville) : 183

Pajonk, F.G. 2003: Varying degree of risks of developing new onset diabetes mellitus in patients treated with atypical antipsychotics. European Neuropsychopharmacology 13(Suppl 4): S300-S301

Tsou, T.C.; Sotoudeh, M.; Li, Y.S.; Shyy, J.Y.J.; Chien, S. 1999: Varying degrees of mechanical stretches induce differential responses of ERK and JNK in vascular smooth muscle cells. FASEB Journal 13(5 Part 2): A856

Sakai, T.; Ichiyama, T.; Hill, G.E.; Whitten, C.W.; Lipton, J.M. 1999: Varying effect of intravenous anesthetics on LPS-stimulated TNF production in human monocytes. Anesthesiology 91(3A): A459

Joshi, I.; Jin, F.; Smith, M.R. 2001: Varying effector mechanisms of rituximab against human B cell lymphoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 775

Sakai, T.; Whitten, C.W.; Hill, G.E.; Lipton, J.M.; Giesecke, A.H. 1999: Varying effects of intravenous anesthetics on LPS-induced TNF-alpha production in human monocytes. Anesthesiology 91(3A): A463

Murray, S.M.; Patil, A.R.; Flickinger, E.A.; Fahey, G.C.Jr 1999: Varying extrusion conditions alter starch fractions in selected cereal grains. FASEB Journal 13(4 Part 1): A231

Goodwin, B.L.; Xi, H.; Eason, D.D.; Ghosh, N.; Wright, K.L.; Nagarajan, U.; Boss, J.M.; Blanck, G. 2001: Varying functions of specific MHC class II transactivator promoter III and IV elements in melanoma cell lines. FASEB Journal 15(4): A658

Down, J.D.; Johnson, K.W.; Morgan, P.G.; Hope, J.A.; White Scharf, M.E. 2000: Varying levels of MHC-mismatched donor-type chimerism associated with different non-myeloablative transplant conditioning regimens. Blood 96(11 Part 1): 172a-173a

Kim, E.C.; Zheng, S.; Zhu, Y.; Lance, P. 2000: Varying levels of prostanoid synthesis in fibroblasts from normal and neoplastic colon. Gastroenterology 118(4 Suppl 2 Pt 1): A54

Reeves, P.G. 2004: Varying media zinc, iron, and calcium affects uptake and transport of cadmium in Caco-2 cells. FASEB Journal 18(4-5): Abstract 364

Walles, T.; Goerler, H.; Macchiarini, P.; Haverich, A.; Mertsching, H. 2003: Varying neointima development in the inflow and outflow conduits of artificial hearts. International Journal of Artificial Organs 26(7): 585

Gupta, A.K.; Agarwal, A.; Saleh, R.A.; Ranganathan, P.; Kattal, N.; Sharma, R.K.; Thomas, A.J. 2003: Varying patterns of spermiograms in men evaluated for infertility A retrospective review of 693 infertility cases. Journal of Urology 169(4 Suppl): 453

Meissner, U.; Stohr, M.; Martin, A.; Markl, J. 2002: Varying quaternary structure of the arthropod hemocyanin superfamily. Zoology (Jena) 105(Suppl 5): 53

Burkhalter, T.M.; Merchen, N.R.; Patil, A.R.; Bauer, L.L.; Murray, S.M.; Fahey, G.C.Jr 1999: Varying ratios of insolublesoluble fiber in soybean hulls affect nutrient digestibilities by ileal cannulated dogs. Journal of Animal Science 77(Suppl 1): 190

Staley, J.T.; Stewart-Jones, A.; Pope, T.W.; Wright, D.J.; Leather, S.R.; Hadley, P.; Rossiter, J.T.; van Emden, H.F.; Poppy, G.M. 2010: Varying responses of insect herbivores to altered plant chemistry under organic and conventional treatments. Proceedings. Biological Sciences 277(1682): 779-786

Guan, L.; Elstrom, R.L.; Zhuang, H.M.; Schuster, S.J.; Alavi, A. 2003: Varying sensitivity of FDG-PET in detecting different subtypes lymphomas by WHO classification. Journal of Nuclear Medicine 44(5 Suppl): 417P

Gorog, D.A.; Tanno, M.; Kabir, A.M.N.; Kanaganayagam, G.S.; Fisher, S.G.; Bassi, R.; Marber, M.S. 2003: Varying susceptibility to myocardial infarction among C57BL/6 of different genetic background. European Heart Journal 24(Abstract Suppl): 175

Haffenden, A.M.; Goodale, M.A. 1999: Varying target location interferes with the influence of learned associations between color and size on visually guided grasping. IOVS Investigative Ophthalmology and Visual Science 40(4): S751

Ritter, R.C. 2000: Varying the gain on control of food intake and body weight Nutritional and endocrine modulation of gut peptide actions. Regulatory Peptides 86(1-3): 29

Lamberton, J.S.; Christian, A.T. 2003: Varying the nucleic acid composition of short interfering molecules greatly varies the degree and duration of gene silencing. Environmental and Molecular Mutagenesis 41(3): 185

Billis, A.; Freitas, L.L.L.; Magna, L.A. 2002: Vas deferens involvement in radical prostatectomies Prevalence and significance. Laboratory Investigation 82(1): 155A-156A

Spellacy, W.N. 2003: Vasa previa, multiple pregnancies, and in vitro fertilization clarification. Fertility and sterility 79(5): 1254-5; author reply 1255

Kantor, B.; Jorgensen, S.M.; Lund, P.E.; Ritman, E.L. 2001: Vasa vasorum are injured in stented coronary arteries Impact of stenting on vessel wall perfusion. Circulation 104(17): 2; 507

Herrmann, J.; Lerman, L.O.; Rodriguez Porcel, M.G.; Holmes, D.R.Jr; Richardson, D.M.; Ritman, E.L.; Lerman, A. 2001: Vasa vasorum neovascularization temporally precedes endothelial dysfunction of the epicardial host vessel in experimental hypercholesterolaemia. European Heart Journal 22(Abstract Suppl): 568

Martin, D.K.; Markhotina, N.; Liu, G.J. 2001: Vascoactive peptides induce relaxation in retinal pericytes via a pathway mediated by protein kinase A. IOVS Investigative Ophthalmology and Visual Science 42(4): S112

D.T.mmaso, L.; Parmeggiani, A.; Castaldini, L.; Foschini, M.P.; Eusebi, V. 2003: Vascular 3D features in normal and pathological thyroid tissue. Virchows Archiv 443(3): 292

E.R.yes, B.F.; Amm, J.M.rie A.; Sondheimer, J.H.; Andersen, J.C. 2002: Vascular Access Thrombosis and Hypercoagulable States in Patients with End Stage Renal Disease on Hemodialsis. Blood 100(11): Abstract No. 1031

Garderet, L.; Carbonnel, N.; Lesage, S.; Isnard, F.; Poupon, R.; Najman, A. 2002: Vascular Amyloidosis Induces Severe Gastrointestinal Bleeding in Patients with Monoclonal Gammopathy. Blood 100(11): Abstract No. 5032

Blaschke, F.; Hintz, O.; Kappert, K.; Doerr, G.; Schmidt, G.; Fleck, E.; Graf, K. 2000: Vascular Beta -integrin-mediated functions are enhanced by hypoxia. European Heart Journal 21(Abstract Suppl): 635

Gattone, V.H.; Sandoval, R.M.; Phillips, C.L. 2004: Vascular Changes in Rodent Polycystic Kidney Disease. FASEB Journal 18(4-5): Abstract 534

Weksler, B.B.; Camilli, T.; Kazior, A.; Subbaramaiah, K.; Dannenberg, A.J. 2002: Vascular Cyclooxygenase-2 Is Upregulated by Tobacco Smoke Directly and by Potentiation of Cytokine-Mediated Gene Effects. Blood 100(11): Abstract No. 2695

Giles, W.B. 1999: Vascular Doppler techniques. Obstetrics and Gynecology Clinics of North America 26(4): 595-606 Vi

Lund, D.D.; Gunnett, C.A.; Mcdowell, A.K.; Brooks, R.M.; Chu, Y.; Faraci, F.M.; Heistad, D.D. 2004: Vascular Dysfunction is Greater When iNOS is Expressed in Endothelium Rather Than Adventitia. FASEB Journal 18(4-5): Abstract 821

Shinkaruk, S.; Bayle, M.; Lain, G.; Deleris, G. 2003: Vascular Endothelial Cell Growth Factor , an emerging target for cancer chemotherapy. Current Medicinal Chemistry - Anti-Cancer Agents 3(2): 95-117

Usnarska Zubkiewicz, L.; Mazur, G.; Wrobel, T.; Poreba, M.; Kuliczkowski, K. 2002: Vascular Endothelial Growth Factor Correlates with Clinical Outcome in Advanced State of Multiple Myeloma. Blood 100(11): Abstract No. 5080

Ellis, P.E.; Wong, T.F.ng, L.F.; Rolfe, K.J.; Crow, J.C.; Maclean, A.B.; Perrett, C.W. 2000: Vascular Endothelial Growth Factor and disease progression in Pagets disease of the vulva and the breast. Journal of Pathology 192(Suppl): 23A

Laurence, L.; Didier, B.; Alain, P.; Francois, D.; Jill Patrice, C.; Gilles, P. 2003: Vascular Endothelial Growth Factor and tumor necrosis factor -alpha expression in myelodysplastic patients treated by Thalidomide. Leukemia Research 27(Suppl 1): S115-S116

Mari, C.; Vanderheyden, J.L.; Mandl, S.J.; Backer, J.M.; Backer, M.V.; Blankenberg, F.G. 2003: Vascular Endothelial Growth Factor driven radionuclide imaging using a universal technetium 99m labeled human ribonuclease based vehicle. Journal of Nuclear Medicine 44(5 Suppl): 298P-299P

Datta, S.; Fildes, J.; Deiraniya, A.K.; Yonan, N.; Hutchinson, I.V. 2003: Vascular Endothelial Growth Factor gene polymorphism are associated with acute rejection after heart transplantation. Journal of Heart and Lung Transplantation 22(1S): S163

Chico, T.J.; Greve, J.; Steinmetz, H.; Hoeffel, J.; Daugherty, A.; Williams, S.P.; Bunting, S.; Van Bruggen, N. 2003: Vascular Endothelial Growth Factor induces both angiogenesis and arteriogenesis independently of nitric oxide. Journal of the American College of Cardiology 41(6 Suppl A): 280A

Laursen, H.; Broholm, H. 2000: Vascular Endothelial Growth Factor receptor neuropilin-1 in primary neoplasms of the central nervous system. Brain Pathology 10(4): 735

Donatucci, C.; Rao, D.; Byrne, R.; Henry, G.; Hagan, P.O.; Annex, B. 2001: Vascular Endothelial Growth Factor restores corporal smooth muscle vasoactive function in the hypercholesterolemic New Zealand White rabbit. European Urology 39(Suppl 5): 107

Bank, A.J.; Sih, R.T.; Mullen, K.; Lee, P. 1999: Vascular K+ATP channels, nitric oxide and human forearm reactive hyperemia. Journal of the American College of Cardiology 33(2 Suppl A): 232A

Wang, X.; Wu, J.; Li, L.; Mukiibi, J.; Jiang, C. 2003: Vascular KATP channels tissue expression and current activation during hypercapnic acidosis. FASEB Journal 17(4-5): Abstract 310

Son, S.M.; Lee, M.S.; Kim, C.D.; Lee, W.S.; Hong, K.W.; Kim, Y.K.; Kim, I.J. 2001: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in OLETF rats. Diabetes 50(Suppl 2): A167

Kleschyov, A.L.; Muller, B.; Stoclet, J.C.; Munzel, T. 2001: Vascular NO production Alone or together with iron?. Circulation 104(17): 2; 302

Roskelley, E.M.; Rebimbas Cohen, B.C.; Spitsbergen Phd, J.M. 2004: Vascular Nerve Growth Factor is Positively Correlated with Arterial Hypertension. FASEB Journal 18(4-5): Abstract 697

Orbe, J.J.; Martin Trenor, A.; Rabago, G.; Lopez Coronado, J.L.; Paramo, J.A. 2000: Vascular PAI-1 expression in grafts used for aorto-coronary bypass surgery. Journal of Submicroscopic Cytology and Pathology 32(3): 415

Paulitschke, M.; Mall, J.; Buettemeyer, R.; Meyer, R.; Wolff, A.; Rademacher, A. 2002: Vascular PTFE grafts endothelialised under defined flow From in vitro data to clinical use. International Journal of Artificial Organs 25(7): 632-634

Rauscher, F.M.; Selvakumar, B.; Lopes, N.; Ma, Q.; Gregg, D.; Dong, C.; Goldschmidt Clermont, P.J. 2002: Vascular Rac1 activity accelerates atherosclerosis progression through superoxide radical production. Circulation 106(19): II123

Lovoi, P.A. 2001: Vascular X-ray probe. Official Gazette of the United States Patent and Trademark Office Patents 1252(3)

Khan, F. 1999: Vascular abnormalities in Raynaud's phenomenon. Scottish Medical Journal 44(1): 4-6

Ross Cisneros, F.N.; Win, P.H.; Carelli, V.; Sadun, A.A. 2001: Vascular abnormalities in optic nerves from two cases of lebers hereditary optic neuropathy. IOVS Investigative Ophthalmology and Visual Science 42(4): S625

Cheung, A.T.W.; Chan, M.S.; Ng, B.C.; Shannon, C.M.; Chow, J.; Chen, P.C.Y.; Larkin, E.C.; Wun, T. 1999: Vascular abnormalities in sickle cell disease. FASEB Journal 13(5 Part 2): A1118

Wang, G.; Wang, M. 2001: Vascular abnormalities of the colon in older Chinese. Journal of the American Geriatrics Society 49(8): 1128-1129

Cameron, N.E.; Cotter, M.A. 2000: Vascular abnormalities, impaired nerve perfusion and function in diabetes mellitus. Journal of Neurochemistry 74(Suppl ): S48

Caplin, N.J.; Reddy, B.; Martin, N. 2003: Vascular access Equal intervention for all. Journal of the American Society of Nephrology 14(Abstracts Issue): 240A

Besarab, A. 2004: Vascular access: issues and management. Contributions to Nephrology 142: 29-46

Walworth, C.; Friedman, A.; Mesler, D.; Meehan, C.; Wander, H.; Shemin, D.; Desoi, B.; Hill, C.; Lambert, C.; Kitsen, J. 2000: Vascular access Variations in new dialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 200A

Klassen, P.S.; Szczech, L.; Reddan, D.N.; Frankenfield, D.L.; Rocco, M.V.; Owen, W.F. 2000: Vascular access and dose of hemodialysis Findings from the 1999 ESRD Clinical Performance Measures Project. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 187A-188A

Verlee, P.; Hofmaster, P.; Silver, T.; Vom Eigen, P.; Rowe, M.; Gallupe, C.; Piper, W.; Malenka, D. 2004: Vascular access and fluoroscopy in percutaneous coronary interventions A quality improvement project. Journal of the American College of Cardiology 43(5 Suppl A): 62A

Barril, G.; Cirugeda, A.; Perpen, A.F.; Alvarez, V.; Bernis, C.; Schez Tomero, J.A.; Traver, J.A.; Selgas, R. 1999: Vascular access assessment by dilutional methodology. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 201A

Wilson, J.; Hanna, S.; Chen, J.; Hall, R.C.; Bryant, T. 2001: Vascular access device. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Sanfilippo, Dominic Joseph, II 1999: Vascular access device and method of installing same. Official Gazette of the United States Patent and Trademark Office Patents 1224(1)

Blatter, D.D. 2003: Vascular access devices and systems. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)

Mooney, C.R.; Currier, C.E. 2003: Vascular access devices having hemostatic safety valve. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)

Macrae, J.M.; Stevens, L.; Yan, S.C.; Karim, M.; Djurdjev, O.; Kiaii, M. 2002: Vascular access distribution in prevalent hemodialyis patients in British Columbia, Canada. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 408A

Young, E.W.; Dykstra, D.; Piera, L.; Pisoni, R.L.; Maroni, B.L. 2000: Vascular access failure and timing of first cannulation. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 201A

Lopot, F.; Sulkova, S.; Nejedly, B.; Blaha, J.; Bodlakova, B. 2002: Vascular access flow and haemodynamic parameters-interrelation and changes during haemodialysis. Blood Purification 20(5): 499

Barril, G.; Besada, E.; Andrino, T.; Cigarran, S.; Cirugeda, A.; Perpen, F.; Selgas, R. 2000: Vascular access follow-up by dilutional methodology. Nephrology Dialysis Transplantation 15(9): A185

Mickley, V. 2003: Vascular access for acute dialysis. Intensivmedizin und Notfallmedizin 40(3): 247-255

Granata, A.; D'Intini, V.; Bellomo, R.; Ronco, C. 2004: Vascular access for acute extracorporeal renal replacement therapies. Contributions to Nephrology 142: 159-177

Brunori, G.; Verzeletti, F.; Zubani, R.; Movilli, E.; Gaggiotti, M.; Cancarini, G.C.; Maiorca, R. 2001: Vascular access for chronic elderly hemodialysis patients. Nephrology Dialysis Transplantation 16(6): A156

Canaud, B.; Martin, K.; Nguessan, C.; Klouche, K.; Leray-Loragues, H.; Béraud, J.J. 2001: Vascular access for extracorporeal renal replacement therapies in the intensive care unit in clinical practice. Contributions to Nephrology 132: 266-282

Mcgrath, J.S.; Shehata, M.; Rigg, K.M. 1999: Vascular access for haemodialysis - A single centre six-year prospective follow-up study. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 212A

Garcia Valsecasas, J.; Martin Malo, A.; Quiroga, P.A.; Castilla, J.; Ramos, B.; Garcia Rotlan, J.; Espinosa Monteros, J.; Alonso, M. 1999: Vascular access for hemodialysis and its influence over dialysis dose. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 206A

Reddan, D.; Szczech, L.; Klassen, P.; Frankenfield, D.; Rocco, M.; Owen, W., J. 2000: Vascular access for in-center hemodialysis patients Initial findings from the 1999 Clinical Performance Measures Project. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 195A

Pierratos, A.; Goluboff, D.; Ouwendyk, M. 1999: Vascular access for nocturnal hemodialysis. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 215A

Weyde, W.; Letachowicz, W.; Krajewska, M.; Laskowska, G.; Szwedko, M.; Klinger, M. 1999: Vascular access in patients over 65 years of age Is the native arteriovenous fistula the first angioaccess choice?. Nephrology Dialysis Transplantation 14(9): A206

Frajewicki, V.; Kushnir, D.; Sura, O.; Loberman, Z.; Kohan, R. 2002: Vascular access in very old hemodialysis patients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 407A

Sanfilippo, Dominic Joseph, II 2001: Vascular access kit. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)

Stadtlander, K.S.; Altman, S.D. 1999: Vascular access monitoring Comparison of different techniques. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 219A

Hadj Abdelkader, M.; Alphonse, J.C.; Gueret, C.; Raynaud, F.; Ravel, A.; Boyer, L.; Deteix, P. 2002: Vascular access of subjects aged over seventy in hemodialysis Results of a 7 year survery. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 711A

Eliasen, K.A.; Powers, K.B.; Christian, K.J. 2001: Vascular access port with elongated septum. Official Gazette of the United States Patent and Trademark Office Patents 1245(2)

Schneditz, D.; Krivitski, N. 2004: Vascular access recirculation: measurement and clinical implications. Contributions to Nephrology 142: 254-268

Lawrence, W.K. 2003: Vascular access sheath. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)

Hurley, E.J.; Lennon, R.; Verghese, M.; Singh, M.; Holmes, D.R.; Bell, M.R.; Rihal, C.S. 2004: Vascular access site complications post percutaneous coronary intervention. Journal of the American College of Cardiology 43(5 Suppl A): 95A-96A

Roca Tey, R.; Samon, R.; Ibrik, O.; Herranz, J.J.; Viladoms, J. 2002: Vascular access surveillance by measuring blood flow rate in 65 patients using the ultrafiltration method. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 286

Young, E.W.; Goodkin, D.A.; Dykstra, D.M.; Port, F.K.; Held, P.J. 1999: Vascular access survival and prior access placement. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 223A

Ramage, I.I.; Tyerman, K.S.; Bailie, A.; Mccoll, J.H.; Pollard, S.G.; Fitzpatrick, M.M.; Brocklebank, T. 2001: Vascular access survival in children and adolescents. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 300A-301A

Kant, K.S.; Duncan, H.J.; Roy Chaudhury, P. 2003: Vascular access thrombosis Role of lipoprotein and acute phase reactants. Journal of the American Society of Nephrology 14(Abstracts Issue): 507A

Amm, Jose Marie A.; El Rayes, Basil F.; Andersen, Judith C.; Sondheimer, James H. 2002: Vascular access thrombosis and hypercoagulable states. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 713A

Palomo, I.án.; Pereira, J.; Alarcón, M.; Vasquez, M.; Pierangeli, S. 2002: Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron 92(4): 957-958

Goldstein, S.L.; Allsteadt, A. 2001: Vascular access thrombosis rates in pediatric hemodialysis patients are decreased with monthly VA flow monitoring by ultrasound dilution. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 289A

Walters, B.A.J.; Delahunty, M.I.; Pennell, P. 2003: Vascular access type influences variation in mean delivered dialysis dose leading to underdialysis. Journal of the American Society of Nephrology 14(Abstracts Issue): 238A-239A

Pisoni, R.L. 2002: Vascular access use and outcomes: results from the DOPPS. Contributions to Nephrology 137: 13-19

Laboi, P.; Anijeet, H.K.I.; Reddy, V.; Turney, J.H.; Bhandari, S. 2002: Vascular access using dialysis catheters exacerbates anemia in hemodialysis patients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 582A

Cao Huu, T.; Ladriere, M.; Frimat, L.; Bellou, M.; Panescu, V.; Hubert, J.; Kessler, M. 1999: Vascular accesses for elderly patients in hemodialysis A five-year-retrospective study. Nephrology Dialysis Transplantation 14(9): A175

Dolmans, D.E.J.G.J.; Kadambi, A.; Hill, J.; Waters, C.; Robinson, B.; Walker, J.; Fukumura, D.; Jain, R.K. 2002: Vascular accumulation of a novel photosensitizer MV6401 contributes to selective thrombosis in tumor vessels following photodynamic therapy. Proceedings of the American Association for Cancer Research Annual Meeting 43: 842

Mockros, L.F.; Fildes, J.M.; Chandran, K.B.; Vonesh, M.J.; Mcpherson, D.D.; Nagaraj, A.; Davidson, C. 1999: Vascular acoustic emission analysis in a balloon angioplasty system. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)

Wu, F.I.; Nagarai, A.; Fildes, J.M.; Davidson, C.J.; Mockros, L.F.; Mcpherson, D.D. 2003: Vascular acoustic emission parameters better identify and characterize angioplasty-induced injury. Journal of the American College of Cardiology 41(6 Suppl A): 2A

Mcdaid, J.; Docherty, J.R. 2001: Vascular actions of MDMA involve alpha-adrenoceptors and 5-HT receptors. British Journal of Pharmacology 133(Proceedings Suppl): 110P

Wakabayashi, I.; Groschner, K. 2003: Vascular actions of anthracycline antibiotics. Current Medicinal Chemistry 10(5): 427-436

D.D.os, S.T.; Jennings, G.L.R.; Dilley, R.J.; Little, P.J. 2003: Vascular actions of anti-diabetic thiazolidinediones. Diabetologia 46(Suppl 2): A51

Jankowski, J.; Tepel, M.; Giet, M.; Zidek, W.; Schlueter, H. 2000: Vascular actions of diadenosine phosphates. Nephrology Dialysis Transplantation 15(9): A30

Baker, K.E.; Broadley, K.J. 2003: Vascular actions of ecstasy Roles of adrenergic neurones, endothelin, thromboxane, 5HT, angiotensin and alpha1-receptors. British Journal of Pharmacology 138(Proceedings Suppl): 166P

Thomas, T.; Rhodin, J. 2000: Vascular actions of estrogen and Alzheimer's disease. Annals of the new York Academy of Sciences 903: 501-509

Muro, M.; Llorente, S.; Marin, L.; Moya, R.; Minguela, A.; Gonzalez, M.; Gimeno, L.; Alemany, J.; Lopez, M.; Garcia, A.; Alvarez, R. 2004: Vascular acute rejection mediated by HLA antibodies in a kidney recipient FlowPRA and CDC vs luminex screening discrepancies. Genes and Immunity 5(Suppl 1): S30

D.G.oot, P.; Van Kuppevelt, D.; Pons, C.; Snoek, G.; Hopman, M. 2002: Vascular adaptations during the first 13 months after spinal cord injury. Medicine and Science in Sports and Exercise 34(5 Suppl): S132

Sun, P.J.; Lalor, P.F.; Wakelam, M.J.O.; Adams, D.H. 2003: Vascular adhesion protein-1 ligation and enzyme activity lead to PI-3 kinase dependent activation of NF-kappaB in hepatic sinusoidal endothelial cells. Hepatology 38(4 Suppl 1): 647A

Guimarães, S.; Moura, D. 2001: Vascular adrenoceptors: an update. Pharmacological Reviews 53(2): 319-356

Chowienczyk, P. 2002: Vascular ageing. Clinical Science 102(5): 601-602

Perings, S.M.; Kelm, M.; Grubert, N.; Schulz, K. 2001: Vascular ageing is associated with a reduction of bioavailable NO. European Heart Journal 22(Abstract Suppl): 60

Stehouwer, C.D.A.; Schram, M.T.; Chaturvedi, N.; Fuller, J.H.; Eurodiab Prospective Complications Study Group 2003: Vascular aging in young type 1 diabetic individuals The EURODIAB Prospective Complications Study. Diabetologia 46(Suppl 2): A 361

Pares, J.; Gallardo, I.; Lopez, J.J.; Ibarra, M.; Villalobos, R. 2003: Vascular alpha1-adrenoceptors in isolated arteries of spontaneously hypertensive rats during aging. Methods and Findings in Experimental and Clinical Pharmacology 25(Suppl A): 152

Briffaut, D.; Tounian, P.; Aggoun, Y.; Sidi, D.; Bonnet, D.; Girardet, J.P. 2001: Vascular alterations associated with dominantly-inherited hypercholesterolemia in children. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 394

Tounian, P.B.; Aggoun, Y.; Dubem, B.; Varille, V.; Bonnet, D.; Sidi, D.; Girardet, J.P. 2000: Vascular alterations associated with obesity in children. Clinical Nutrition 19(Suppl 1): 48

Crespo, M.J.; Moreta, S.; Gonzalez, J.A. 2002: Vascular alterations precede cardiac dysfunction in Syrian cardiomyopathic hamsters. FASEB Journal 16(4): A436

Calhoun, M.E.; Burgermeister, P.; Phinney, A.L.; Stalder, M.; Tolnay, M.; Sommer, B.; Staufenbiel, M.; Jucker, M. 1999: Vascular amyloid in an APP transgenic mouse model Neurodegeneration and mechanisms. Society for Neuroscience Abstracts 25(1-2): 1291

Realyvasquez, F.J.; Weinstein, M.J.; Valerio, M.A. 2003: Vascular anastomosis device. Official Gazette of the United States Patent and Trademark Office Patents 1272(4)

Isogai, S.; Subramanian, R.; Bennett, P.E.; Weinstein, B.M. 1999: Vascular anatomy of the developing zebrafish. Developmental Biology 210(1): 211

Guzman, J.C.; Leon, H.; Garcia, R.G.; Casas, J.P.; Silva, F.A.; Lopez Jaramillo, P.; Morillo, C.A. 2004: Vascular and autonomic dysfunction in the asymptomatic stage of Chagass disease. Journal of the American College of Cardiology 43(5 Suppl A): 204A

Baguet, J.P.; Douchin, S.; Siche, J.P.; Rossignol, A.M.; Tremel, F.; Mallion, J.M. 2001: Vascular and blood pressure modifications in Turners syndrome. American Journal of Hypertension 14(4 Part 2): 130A

Abd, E.S., A.; Meraney, A.M.; Schweizer, D.K.; Savage, S.J.; Sung, G.T.; Gill, I.S. 2000: Vascular and bowel complications following retroperitoneoscopy. Journal of Endourology 14(Suppl 1): A93

Sguazzin, F.; Polli, E. 2001: Vascular and bryological flora of the Julian pre-Alps caves Foran di Landri and Foran des Aganis Contribution to the speleoflora of Friuli-Venezia Giulia. Gortania Atti del Museo Friulano di Storia Naturale 23: 93-112

Douglas, S.A.; Ohlstein, E.H. 2001: Vascular and cardiac effects of endothelin. Warner, Timothy D Handbook of Experimental Pharmacology Endothelin and its inhibitors 405-451

Boutcher, S.H.; Hamer, M.; Boutcher, Y. 2002: Vascular and cardiac reactivity to stress in highly and moderately active offspring hypertensives. Medicine and Science in Sports and Exercise 34(5 Suppl): S161

Morris, R.E. 2001: Vascular and cellular mechanisms of chronic renal allograft dysfunction. Transplantation 71(11 Suppl): Ss37-Ss41

Doss, B.J.; Qureshi, F.; Mayes, M.D.; Jacques, S.M. 1999: Vascular and connective tissue alterations in the female lower genital tract in scleroderma. Modern Pathology 12(1): 115A

Alt, E. 2002: Vascular and endoluminal stents. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)

Alt, E. 2000: Vascular and endoluminal stents with improved coatings. Official Gazette of the United States Patent and Trademark Office Patents 1237(2)

Alt, E.; Stotts, L.J. 1999: Vascular and endoluminal stents with iridium oxide coating. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)

Rovirosa, A.; Ascaso, C.; Ordi, J.; Abellana, R.; Arenas, M.; Lejarcegui, J.; Pahisa, J.; Puig Tintore, L.I.X.; Biete, A. 2000: Vascular and lymphatic space invasion as a main prognostic factor in uterine sarcomas. Radiotherapy and Oncology 56(Suppl 1): S145

Scollard, D.M. 2000: Vascular and lymphocytic changes in the Lucio reaction. Laboratory Investigation 80(3): 67A

Bøtker, H.E. 2001: Vascular and metabolic abnormalities in patients with angina pectoris and normal coronary angiograms. Danish Medical Bulletin 48(1): 1-18

Carmeliet, P.; Storkebaum, E. 2002: Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Seminars in Cell and Developmental Biology 13(1): 39-53

George, M.; Van Thiel, D.H. 2002: Vascular and nonvascular biomarkers in patients with chronic hepatitis C Relationship to the response to therapy. Hepatology 36(4 Part 2): 595A

Dohil, M.A.; Baugh, W.P.; Eichenfield, L.F. 2000: Vascular and pigmented birthmarks. Pediatric Clinics of North America 47(4): 783-812 V-VI

Schaefer, K.; Hecke, A.; Mueller, K.; Goebel, J.; Mounier, E.; Konstantinides, S. 2002: Vascular and platelet expression of plasminogen activator inhibitor-1 contributes to the prothrombotic phenotype of apoE-knockout mice. Circulation 106(19): II80

Schnermann, J.B.; Hashimoto, S.; Bernstein, K.E.; Briggs, J.P. 2002: Vascular and proximal tubule function without tissue ACE Studies in ACE2 mice. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 148A

Cao, Z.; Casley, D.; Cooper, M.E. 2000: Vascular and renal expression of the angiotensin type 2 receptor Modulation by angiotensin II. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 451A

Fidelis, P.; Rusell, A.; Oyekan, A.O. 2004: Vascular and renal function in mice lacking the Peroxisome Proliferator Activated Receptor alpha. FASEB Journal 18(4-5): Abstract 439

Wang, D.; Strandgaard, S. 2000: Vascular and renal nitric oxide synthase activity is impaired in polycystic kidney disease rats. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 400A

Ibusuki, T.; Saito, E.; Kambe, T.; Kubo, T. 2000: Vascular angiotensin system is enhanced in young spontaneously hypertensive rats. Japanese Journal of Pharmacology 82(Suppl 1): 210P

Nitta, M. 2000: Vascular anomalies of head and neck. Jibi Inkoka Tokeibu Geka 72(4): 247-250

Banks, N.; Collins, J.D.; Saxton, E.H.; Ahn, S.S.; Miller, T.Q.; Carnes, A.; Agnew, D. 2002: Vascular anomalies of the brachial plexus as displayed by MRI and MRA. FASEB Journal 16(4): A380

Godefroy, O.S.; Dubois, C.; Debachy, B.; Leclerc, M.; Henguelle, C.; Leys, D.R. 1999: Vascular aphasias. Neurology 52(6 Suppl 2): A239-A240

Zagzag, D.; Amirnovin, R.; Greco, A.; Yee, H.; Holash, J.; Wiegand, S.; Yancopoulos, G.; Grumet, M. 2000: Vascular apoptosis and involution in glioma progression is associated with angiopoietin-2 expression. Brain Pathology 10(4): 735-736

Masuda, S.; Hayashi, H.; Araki, S. 2000: Vascular apoptosis-inducing proteins from snake venom. Cell Structure and Function 25(6): 498

Masuda, S.; Araki, S.; Hayashi, H. 2000: Vascular apoptosis-inducing proteins from snake venom are members of the metalloprotease/disintegrin family. Journal of Submicroscopic Cytology and Pathology 32(3): 341

Chung, H.S.; Harris, A.; Evans, D.W.; Kagemann, L.; Garzozi, H.J.; Martin, B. 1999: Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Survey of Ophthalmology 43(Suppl 1): S43-S50

McIntire, L.V. 2002: Vascular assembly in engineered and natural tissues. Annals of the new York Academy of Sciences 961: 246-248

Skalak, T.C.; Little, C.D.; McIntire, L.V.; Hirschi, K.K.; Tranquillo, R..T.; Post, M.; Ranieri, J. 2002: Vascular assembly in engineered and natural tissues: breakout session summary. Annals of the new York Academy of Sciences 961: 255-257

Hirschi, K.K.; Skalak, T.C.; Peirce, S.M.; Little, C.D. 2002: Vascular assembly in natural and engineered tissues. Annals of the new York Academy of Sciences 961: 223-242

Arkans, E.J. 1999: Vascular assist methods and apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

De la Torre, J.C. 2002: Vascular basis of Alzheimer's pathogenesis. Annals of the new York Academy of Sciences 977: 196-215

Cai, Y.; Yan, M.; Lim, Y.L.; Wang, Y.; Chui, C. 2000: Vascular bifurcation modeling. Chest 118(4 Suppl): 227S-228S

Jacobsen, D.W.; Dibello, P.M.; Budy, B.; Majors, A.K.; Sengupta, S. 2003: Vascular biochemistry of homocysteine Implications for cardiovascular disease. Molecular and Cellular Proteomics 2(9): 676

Lazar, H.L.; Bao, Y.; Rivers, S.M. 1999: Vascular biology of cardioplegic protection Improved endothelial function may translate into greater reduction in infarct size. Circulation 100(18): 1; 228

Meddahi-Pellé, A.; Bataille, I.; Subra, P.; Letourneur, D. 2004: Vascular biomaterials: from biomedical engineering to tissue engineering. Medecine Sciences: M/S 20(6-7): 679-684

Rosen, J.J.; Hillstead, R.A.; Weldon, T.D.; Larsen, C.E.; Williams, D.O. 1999: Vascular blood containment device. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)

Padilla, W.; Nelson, A.D.le 1999: Vascular blood flashback containment device with improved sealing capability. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)

Sampaolesi, J.; Sampaolesi, R. 2001: Vascular blood flow in different optic nerve head neuropathies. International Ophthalmology 23(4-6): 369-371

Do, H.P.; Pasche, G.; Latchem, D.; De Benedetti, E.; Roguelov, C.; Stauffer, J.C.; Goy, J.J.; Urban, P.; Eeckhout, E.; Coucke, P.A. 2001: Vascular brachytherapy for in-stent restenosis in coronary arteries The Lausanne experience on 98 patients. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 147

Costantini, C.O.; Lansky, A.J.; Mehran, R.; Mintz, G.S.; Desai, K.; Shirai, K.; Marginean, H.; Stone, G.W.; Dangas, G.; Leon, M.B. 2002: Vascular brachytherapy for ostial in-stent restenotic lesions. Journal of the American College of Cardiology 39(5 Suppl A): 46A

Reilly, J.P.; Ramee, S.R. 2004: Vascular brachytherapy in renal artery restenosis. Current Opinion in Cardiology 19(4): 332-335

Gershlick, A.H.; Lloyd, A.S.ephens 2001: Vascular brachytherapy may attenuate the adverse effects of poor acute angiographic result in in-stent restenosis. Circulation 104(17): 2; 576

Wolfram, R.M.; Budinsky, A.C.; Pokrajac, B.; Sabeti, S.; Bartok, A.; Poetter, R.; Minar, E. 2004: Vascular brachytherapy with 192Iridium after femoropopliteal stenting in high-risk patients Results from the vienna-5 trial. Journal of the American College of Cardiology 43(5 Suppl A): 32A

Debruyne, Philippe; Wijns, William; Ribichini, Flavio; Mercado, Nestor; Piessens, Marleen; Barbato, Emanuele; Ferrero, Valeria; Heyndrickx, Guy R.; Verbeke, Luc; De Bruyne, Bernard 2001: Vascular brachytherapy with de novo stenting predisposes to side branch occlusion. Circulation 104(17): 2; 545-II 546

Niu, X.; Wang, H.; Tomes, D. 2001: Vascular bundle-specific expression directed by two stalk-preferred promoters in transgenic maize. Plant Biology (Rockville) : 153

Miller, A.; Allen, W.J. 2004: Vascular bypass grafting instrument and method. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)

Pinto, I.; Sampaio, S.; Pires, A.; Bernardo, I.; Santos, V. 2002: Vascular calcification in hemodialysis patients Evaluation of risk factors. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 259

Spiegel, D.M.; Raggi, P.; Mehta, R.; Lindberg, J.S.; Chonchol, M.; Chertow, G.M.; Block, G.A. 2003: Vascular calcification in patients new to hemodialysis. Journal of the American Society of Nephrology 14(Abstracts Issue): 695A

Moe, S.M.; Duan, D.; O'neill, K.D.; Chen, N.X. 2001: Vascular calcification is associated with expression of Cbfa1, a bone transcription factor. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 756A

Jang, Y.e Teh 2004: Vascular catheter having low-profile distal end. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Noordenbos, J.; Dore', C.; Hansbrough, J. 1999: Vascular catheter infections A three year review. Journal of Burn Care and Rehabilitation 20(1 Part 2): S145

Siegman Igra, Yardena; Golan, Haim; Schwatrz, David; Cahaner, Yona; De Mayo, Gili; Orni Wasserlauf, Ruth 1999: Vascular catheter-related bloodstream infections. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 62

Sherertz, R.J.; Jarvis, W.R. 2003: Vascular catheters inserted in the trenches versus guideline documents: can the discrepancies be resolved?. Infection Control and Hospital Epidemiology 24(12): 887-889

Mitosek Szewczyk, K.; Stelmasiak, Z.; Belniak Legiec, E.; Bartosik Psujek, H.; Dobosz, B. 2000: Vascular cell adhesion molecule and E-selectin in remitting-relapsing multiple sclerosis treated with cladribine. European Journal of Neurology 7(Suppl 3): 131

Raynor, B.; Brickman, S.; Bonney, E.; Jang, K.T.; Santanam, N.; Parthasarathy, S. 2001: Vascular cell adhesion molecule and low-density lipoprotein oxidation in preeclampsia. American Journal of Obstetrics and Gynecology 184(1): S82

Hernandez, C.; Canton, A.; Burgos, R.; Segura, R.M.; Lecube, A.; Mesa, J.; Garcia Arumi, J.; Simo, R. 2000: Vascular cell adhesion molecule in vitreous of patients with proliferative diabetic retinopathy. Diabetologia 43(Suppl 1): A242

Hession, C.A.; Lobb, R.R.; Goelz, S.E.; Osborn, L.; Benjamin, C.D.; Rosa, M.D. 2001: Vascular cell adhesion molecule polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)

Li, M.S.; Rafiee, P.; Fisher, P.J.; Lamirand, T.H.; Taras, A.R.; Shidham, V.B.; Johnson, C.P.; Binion, D.G. 2000: Vascular cell adhesion molecule-1 expression in human intestinal micro-vascular endothelial cells is mediated by JNK, intracellular oxyradicals and NFkappaB activation. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A613

Dimayuga, P.; Oguchi, S.; Zhu, J.; Chyu, K.Y.; Yano, J.; Xu, X.H.; Shah, P.K.; Nilsson, J.; Cercek, B. 1999: Vascular cell adhesion molecule-1 inhibition reduces neointima formation after arterial injury in apolipoprotein E mice. Circulation 100(18): 1; 547

Kambara, C.; Nakamura, T.; Furuya, T.; Migita, K.; Eguchi, K. 1999: Vascular cell adhesion molecule-1 mediated matrix metalloproteinase-2 induction in peripheral blood T lymphocyte is up-regulated in patients with HTLV-I associated myelopathy. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(4): A48

De Muret, A.; Daste, G.; Vergier, B.; Maugendre Caulet, S.; Verdier, D.; De Baecque, C.; Groussard, O.; Hofman, P.; Grangeponte, M.C.; Lemarie, E.; Capron, F. 1999: Vascular changes in 19 cases of pulmonary lymphangioleiomyomatosis. Revue des Maladies Respiratoires 16(1 Suppl): 1S86

Shin, Y.; Cho, H.S.; Rebeck, G.W.; Greenberg, S.M. 2002: Vascular changes in Iowa-type hereditary cerebral amyloid angiopathy. Annals of the new York Academy of Sciences 977: 245-251

Kemeny, E.; Fricska, A.N.; Szederkenyi, E.; Eller, J.; Morvay, Z.; Illyes, G.; Ivanyi, B.; Szenohradszky, P. 2003: Vascular changes in donor kidneys may have an impact on late graft-dysfunction. Virchows Archiv 443(3): 383

Bailey, M.; Ostrowski, M.L.; Langston, C.A.; Fraire, A.E.; Cagle, P.T. 2000: Vascular changes in lungs from cocaine abusers. Laboratory Investigation 80(3): 206A

Browning, J.; Reichelt, M.; Naug, H.; Gole, G. 2000: Vascular changes in the proximal hyaloid in oxygen-induced retinopathy. IOVS Investigative Ophthalmology and Visual Science 41(4): S336

Franklin, S.S. 2001: Vascular changes of aging. American Journal of Hypertension 14(4 Part 2): 263A

Dokmo, Y.B.; Vesti, E.; Ohman, H.; Sonnsjo, B.I.S. 2000: Vascular changes of the iris in exfoliation syndrome and exfoliation glaucoma. IOVS Investigative Ophthalmology and Visual Science 41(4): S282

Yee, D.T.; Pakalnis, V.A.; Lin, N. 2001: Vascular changes, pathophysiology, anatomy and natural history of iris microhemangiomas associated with spontaneous hyphema. IOVS Investigative Ophthalmology and Visual Science 42(4): S334

Morejohn, D.P.; Septeka, I.; Glines, R.C. 2000: Vascular clamp and method for using the same. Official Gazette of the United States Patent and Trademark Office Patents 1232(2)

Fogarty, T.J.; Hermann, G.D.; Whittemore, J.S.; Howell, T.A. 2000: Vascular clamps and surgical retractors with directional filaments for tissue engagement. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Kringel, B.; Lutze, T.; Schutzbach, L. 2001: Vascular clip. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)

Mcguckin, J.F.J.; Maurer, C.W.; Peters, W.H. 2004: Vascular closure. Official Gazette of the United States Patent and Trademark Office Patents 1283(3)

Resnic, F.S.; Blake, G.J.; Popma, J.J.; Rogers, C. 2000: Vascular closure devices are associated with a reduced risk of vascular complications in patients receiving glycoprotein IIb/IIIa inhibitors. American Journal of Cardiology 86(Suppl 8A): 54i-55i

Ollerenshaw, J.; Yuksel, U.; Black, K.S. 2002: Vascular coating composition. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Rasquin, S.M.C.; Verhey, F.R.J.; Lousberg, R.; Winkens, I.; Lodder, J. 2002: Vascular cognitive disorders: memory, mental speed and cognitive flexibility after stroke. Journal of the Neurological Sciences 203-204: 115-119

Rockwood, K. 2002: Vascular cognitive impairment and vascular dementia. Journal of the Neurological Sciences 203-204: 23-27

Rockwood, K. 2002: Vascular cognitive impairment in clinical practice. Journal of the Neurological Sciences (203-204): 322

Almkvist, O.; Viitanen, M.; Arnesen, E.; Engstad, T. 2002: Vascular cognitive impairment in long-term stroke survivors The Tromso population study. Journal of the Neurological Sciences (203-204): 281-282

Rivers, R.J. 2000: Vascular communication is blocked by lidocaine and bupivicaine. FASEB Journal 14(4): A60

Obuobie, K.; Smith, J.; Ahmed, K.; Davies, J.S.; Lazarus, J.H. 2000: Vascular compliance in hyperthyroidism. Journal of Endocrinology 164(Suppl ): P320

Waring, L.D.; Nair, N.; Umoh, E.M.; Cooke, J.P. 2004: Vascular compliance versus endothelial function Which correlates better to risk factor score?. Journal of the American College of Cardiology 43(5 Suppl A): 468A

Deepa, R.; Anjana, M.; Haranath, S.P.; Saravanan, G.; Rema, M.; Mohan, V. 1999: Vascular complications and serum lipoprotein concentrations in South Indian type 2 diabetic patients. Clinical Chemistry 45(6 Part 2): A10-A11

Locsey, L.; Szegedi, J.; Dan, A.; Gorogh, S.; Toth, E. 2001: Vascular complications connection between hyperhomocysteinaemia and hypertension in haemodialysed patients. Nephrology Dialysis Transplantation 16(6): A147

Sánchez-Bueno, F.; Hernández, Q.; Ramírez, P.; Robles, R.; Acosta, F.; Rodríguez, J.M.; Parrilla, P. 1999: Vascular complications in a series of 300 orthotopic liver transplants. Transplantation Proceedings 31(6): 2409-2410

Seshan, S.V. 2000: Vascular complications in lupus nephritis and lupus-like syndromes. Wiener Klinische Wochenschrift 112(15-16): 687-691

Hiatt, B.L.; Lee, D.P.; Carter, A.J.; Yeung, A.C. 2000: Vascular complications in patients who receive a glycoprotein IIb/IIIa inhibitor and vascular closure with the perclose device. Journal of the American College of Cardiology 35(2 Suppl A): 33A

Eid, A.; Lyass, S.; Venturero, M.; Ilan, Y.; Safadi, R.; Zamir, G.; Berlatzky, Y.; Jurim, O. 1999: Vascular complications post orthotopic liver transplantation. Transplantation Proceedings 31(4): 1903-1904

Pawlak, J.; Wróblewski, T.; Małkowski, P.; Nyckowski, P.; Zieniewicz, K.; Grzelak, I.; Alsharabi, A.; Michałowicz, B.; Krawczyk, M.; Karwowski, A. 2000: Vascular complications related to liver transplantation. Transplantation Proceedings 32(6): 1426-1428

Resnick, D.E.; Jayakar, P.; Duchowny, M.S.; Morrison, G.; Ragheb, J. 2001: Vascular complications secondary to temporal lobe resection for intractable localization-related epilepsy. Epilepsia 42(Suppl 7): 197

Wackym, P.A.; King, W.A.; Weisz, D.J. 1999: Vascular compression of the cochlear nerve identified by endoscopy during acoustic neuroma surgery. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 120(4): 535

Musch, T.I.; Mcallister, R.M.; Symons, J.D.; Hirai, T.; Hageman, K.S.; Poole, D.C. 2001: Vascular conductance during high intensity exercise in rats Effects of nitric oxide synthase inhibition. Medicine and Science in Sports and Exercise 33(5 Suppl): S21

Bouthillier, A.; Thomas, T.E.; Carmant, L.; Cossette, P.; Giard, N.; Saint Hilaire, J.M.rc 2002: Vascular consequences of cortectomies for epilepsy. Epilepsia 43(Suppl 7): 222

Damiano, P.; Roson, I.; Cavallero, S.; Mayer, M.; De La Riva, I.; Puyo, A. 2001: Vascular contractility in rats with chronic fructose overload. Hypertension 37(3): 999

Florian, J.A.; Harris, B.; Watts, S.W. 1999: Vascular contraction to epidermal growth factor is independent of elevated systolic blood pressure in deoxycorticosterone acetate-salt-induced hypertension. FASEB Journal 13(4 Part 1): A37

Sylvester, F.A.; Lombard, J.H. 1999: Vascular control mechanisms differ within the cremaster muscle arterial network. FASEB Journal 13(4 Part 1): A30

Weyand, C.M.; Goronzy, J.J. 2000: Vascular damage in acute coronary syndromes and in rheumatoid arthritis Evidence for shared pathogenic pathways. Pathology International 50(Suppl): A44

Ingaramo, Roberto, A. . 2004: Vascular damage in hypertensive subjects. American Journal of Hypertension 17(5

Schorpp Kistner, M.; Schmidt, D.; Angel, P. 2000: Vascular defects in JunB-deficient embryos can be mimicked by in vitro differentiation of JunB-deficient ES cells. Journal of Submicroscopic Cytology and Pathology 32(3): 407

Hagino, N.; Kobayashi, S.; Tsutsumi, T.; Horiuchi, S.; Nagai, R.; Setalo, G.; Dettrich, E. 2002: Vascular deficiency of hippocampal capillary seems to be associated with memory deficiency. FASEB Journal 16(5): A733

Small, G.W. 2002: Vascular dementia Galantamine as an emerging therapeutic option. Acta Neurologica Scandinavica 106(Suppl 178): 4-5

Bowirrat, A.; Friedland, R.P.; Korczyn, A.D. 2002: Vascular dementia among elderly Arabs in Wadi Ara. Journal of the Neurological Sciences 203-204: 73-76

Bonaffini, N.; Altieri, M.; Mostardini, C.; Mancini, G.; Roberti, C.; Lenzi, G.L.; Zanette, E.M. 2000: Vascular dementia and Alzheimers disease An echocolor Doppler study on extracranial vessel atherosclerosis. European Journal of Neurology 7(Suppl 3): 135-136

Engelberg, H. 2000: Vascular dementia and Alzheimers disease Probable beneficial effects of heparin. FASEB Journal 14(4): A637, Ch 15

Korczyn, A.D. 2002: Vascular dementia and Alzheimers disease Where are the borders?. Journal of the Neurological Sciences (203-204): 309

Ochudlo, S.; Opala, G.; Kalina, Z.; Gorzkowska, A. 2002: Vascular dementia and intima-media complex of carotid arteries. Journal of the Neurological Sciences (203-204): 316

Yanagihara, T. 2002: Vascular dementia in Japan. Annals of the new York Academy of Sciences 977: 24-28

Potic, J.P.J.; Potic, A.; Sujic, R. 2002: Vascular dementia in uremic patients. Journal of the Neurological Sciences (203-204): 320-321

Shahpesandy, H.M.; Doci, I.; Medvecky, M. 2002: Vascular dementia is the most frequent form of dementia in Slovakia. Journal of the Neurological Sciences (203-204): 327-328

Román, G.C. 2002: Vascular dementia may be the most common form of dementia in the elderly. Journal of the Neurological Sciences 203-204: 7-10

Román, G.C. 2002: Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. Medical Clinics of North America 86(3): 477-499

Olbrich, K.C.; Ravin, A.G.; Usala, A.L.; Levin, L.S.; Klitzman, B. 2000: Vascular density and capsule thickness around implanted devices. FASEB Journal 14(4): A445

Peeters, Charlotte Fransisca J.M.; Westphal, Johan R.; Oyen, Wim J.G.; Wobbes, Theo; Ruiter, Dirk J.; De Waal, Robert; Ruers, Theo J.M. 2001: Vascular density and metabolic activity of liver metastases increase after removal of primary colorectal tumors in humans. Proceedings of the American Association for Cancer Research Annual Meeting 42: 696-697

Mattson, G.; Jansson, L.; Carlsson, P.O.a 2001: Vascular density in mouse pancreatic islets decreases after transplantation. Cell Transplantation 10(6): 547

Rossant, J.; Hirashima, M. 2003: Vascular development and patterning: making the right choices. Current Opinion in Genetics and Development 13(4): 408-412

Kurihara, H. 2001: Vascular development and regenerative medicine. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 38(2): 102-108

Ye, Z-Hua.; Freshour, G.; Hahn, M.G.; Burk, D.H.; Zhong, R. 2002: Vascular development in Arabidopsis. International Review of Cytology 220: 225-256

Kurz, H.; Christ, B. 2002: Vascular development of the brain and spinal cord. Tomanek, Robert J Cardiovascular Molecular Morphogenesis Assembly of the vasculature and its regulation 157-191

Tomanek, R.J.; Yue, X.; Zheng, W. 2002: Vascular development of the heart. Tomanek, Robert J Cardiovascular Molecular Morphogenesis Assembly of the vasculature and its regulation 133-155

Gomez, R.A.; Sequeira Lopez, M.L. S. 2002: Vascular development of the kidney. Tomanek, Robert J Cardiovascular Molecular Morphogenesis Assembly of the vasculature and its regulation 193-210

Demello, D.E.; Reid, L.M. 2002: Vascular development of the lung. Tomanek, Robert J Cardiovascular Molecular Morphogenesis Assembly of the vasculature and its regulation 211-237

Nir, S.G.; Cohen, S.; Itskovitz Eldor, J. 2003: Vascular development research using human embryonic stem cells. Developmental Biology 259(2): 531

Shima, D.T.; Mailhos, C. 2000: Vascular developmental biology: getting nervous. Current Opinion in Genetics and Development 10(5): 536-542

Mcguckin, J.F.J.; Briganti, R.T. 2003: Vascular device and method for valve leaflet apposition. Official Gazette of the United States Patent and Trademark Office Patents 1268(1)

Hopkins, L.N.; Khosravi, F.; Salahieh, A.; Demond, J.F.; Lepak, J.; Ramee, S.; Krolik, J.A.; Renati, R. 2003: Vascular device for emboli, thrombus and foreign body removal and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)

Mcguckin, J.F.J.; Briganti, R.T. 2004: Vascular device for valve leaflet apposition. Official Gazette of the United States Patent and Trademark Office Patents 1279(4)

Hopkins, L.N.; Khosravi, F.; Salahieh, A.; Krolik, J.A.; Demond, J.F. 2003: Vascular device having articulation region and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Hopkins, L.N.; Khosravi, F.; Salahieh, A.; Krolik, J.A.; Demond, J.F. 2003: Vascular device having one or more articulation regions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)

Mcguckin, J.F.J.; Hinchliffe, P.W.J. 2004: Vascular device with valve for approximating vessel wall. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)

Endres, S.; Schmidt, E. Berg; Kristensen, S. Dalby; De Caterina, R. 2001: Vascular disease and nutrition. Lipids 36(Suppl): S1-S2

Maitra, S.; Jassal, S.V.; Bargman, J.M. 2001: Vascular disease causes increased mortality in elderly female diabetics on peritoneal dialysis A single center experience. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 432A-433A

Kondo, H. 2001: Vascular disease in mixed connective tissue disease. Internal Medicine (Tokyo) 40(12): 1176

Naidu, S.S.; Vlachos, H.A.; Faxon, D.; Jacobs, A.K.; Johnston, J.M.; Detre, K.; Wilensky, R.L. 2003: Vascular disease independently predicts worse outcome after percutaneous coronary intervention Results from the NHLBI Dynamic Registry. Journal of the American College of Cardiology 41(6 Suppl A): 3A

Clement, D.L.; Belch, J.J.F. 2004: Vascular disease public education: the mandate is international. International Angiology: a Journal of the International Union of Angiology 23(1): 1-4

Neau, J.P. 2001: Vascular diseases and obstructive sleep apnea syndromes. Revue Neurologique (Paris) 157(11 Part 2): 5S34-5S37

Zlokovic, B.V. 2002: Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets. Advanced Drug Delivery Reviews 54(12): 1553-1559

Zoltowska, M.; St Louis, J.; Bar On, H.; Ziv, E.; Sicotte, B.; Stan, S.; Levy, E. 2000: Vascular disorders in diabetic Psammomys rats. FASEB Journal 14(4): A451

Padmanabhan, R.; Maya, T.; Ahmed, I. 2003: Vascular disruption that leads to limb reduction deformities in a rat model. Birth Defects Research 68(3): 264

Galenzoski, K.J.; Prasad, C.; Dawson, A.J.; Chudley, A.E. 2001: Vascular disruption-related birth defects in 22q112 deletion syndromes. American Journal of Human Genetics 69(4 Suppl): 303

Nilsson, B.O.; Andersson, C.; Ferno, M.; Gustafsson, J.A.; Idvall, I.; Lydrup, M.L. 2000: Vascular distribution of oestrogen receptor subtypes. Acta Physiologica Scandinavica 170(4): A63

Yasunari, K.; Kohno, M.; Yoshikawa, J. 1999: Vascular dopamine-1 receptors and atherosclerosis. Clinical and Experimental Pharmacology and Physiology 26(Suppl ): S70

Goldsmith, Harry S.; De La Torre, Jack C. 2004: Vascular dynamics in Alzheimer and vascular dementia. Neurological Research 26(5): 453

Schneemann, S.; Witte, K.; Lemmer, B. 2004: Vascular dysfunction and oxidative stress in type 2 diabetic GK rats. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R44

Pleiner, J.; Fuchsjaeger Mayrl, G.; Francesconi, M.; Wiesinger, G.F.; Sieder, A.E.; Wolzt, M. 2000: Vascular dysfunction can be restored in patients with IDDM by physical training. Diabetes Research and Clinical Practice 50(Suppl 1): S131

Didion, S.; Faraci, F. 2004: Vascular dysfunction in TallyHo mice A new genetic model of type II diabetes. FASEB Journal 18(4-5): Abstract 201

Bhatt, A.; Pryhuber, G.; Huyck, H.; Watkins, R.; Maniscalco, W. 2000: Vascular dysmorphic changes in premature human infants dying with bronchopulmonar dysplasia. Journal of Investigative Medicine 48(2): 213A

Iadecola, C.; Nogawa, S.; Zhao, X.; Niwa, K.; Nagayama, M.; Araki, E.; Morham, S.; Ross, M.E. 1999: Vascular dysregulation and increased susceptibility to cerebral ischemic injury in mice lacking the cyclooxygenase-2 gene. Society for Neuroscience Abstracts 25(1-2): 19

Yousefipour, Z.; Ranganna, K.; Hayes, B.; Oyekan, A.; Milton, S.G. 2002: Vascular effect of acrolein in rats. FASEB Journal 16(4): A39

Nawa, H.; Nakatsuma, A.; Kurosaki, Y.; Kawasaki, H. 1999: Vascular effect of bradykinin in mesenteric resistance blood vessels of the rat. Japanese Journal of Pharmacology 79(Suppl 1): 217P

Longo, M.; Jain, V.; Mackay, L.; Vedernikov, Y.; Facchinetti, F.; Saade, G.; Garfield, R. 2001: Vascular effect of magnesium sulphate in trasgenic mice lacking endothelial nitric oxide synthase. American Journal of Obstetrics and Gynecology 184(1): S78

Bagate, K.; Meiring, J.; Gerlofs Nijland, M.; Vleeming, W.; Vincent, R.; Cassee, F.R.; Borm, P.J.A. 2003: Vascular effect of particle instillation in spontaneous hypertensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R21

Lefer, A.M.; Scalia, R.; Lefer, D.J. 2001: Vascular effects of HMG CoA-reductase inhibitors unrelated to cholesterol lowering New concepts for cardiovascular disease. Cardiovascular Research 49(2): 281-287, 1 February

Berger, E.D.; Bader, B.D.; Hartmann, C.; Risler, T.; Erley, C.M. 2001: Vascular effects of L-NAME in acute hyperglycemia. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 509A

Parnell, M.M.; Kaye, D.M. 2002: Vascular effects of L-NMMA are mediated via actions on eNOS not L-arginine transport. European Heart Journal 23(Abstract Suppl): 173

Horsman, M.R.; Murata, R.; Overgaard, J. 2000: Vascular effects of a novel vascular targeting agent in a C3H mouse mammary carcinoma and murine normal tissues. Proceedings of the American Association for Cancer Research Annual Meeting 41: 328-329

Rump, L.; Stegbauer, J.; Oberhauser, V. 2000: Vascular effects of bioactive components of the renin-angiotensin-system in isolated perfused rat kidneys. Journal of Hypertension 18(Suppl 4): S80

Kirch, W. 1999: Vascular effects of cardiac glycosides. European Journal of Clinical Investigation 29(Suppl 1): 61

Jankowski, J.; Tepel, M.; Van Der Giet, M.; Zidek, W.; Schlueter, H. 2000: Vascular effects of diadenosine phosphates. Kidney and Blood Pressure Research 23(3-5): 346

Johnson, F.K.; Teran, F.J.; Coco, K.C.; Johnson, R.A. 2000: Vascular effects of endogenous carbon monoxide are enhanced in the absence of endothelium-derived nitric oxide. Acta Haematologica (Basel) 103(Suppl 1): 72

Zanger, D.; Blum, A.; Hathaway, L.; Mincemoyer, R.; Panza, J.A.; Schenke, W.H.; Cannon, R.O.IIi 1999: Vascular effects of estrogen therapy in postmenopausal women with coronary artery disease on conventional medical management. Circulation 100(18): 1; 332

Erlinge, D. 2001: Vascular effects of extracellular nucleotides. Kidney and Blood Pressure Research 24(4-6): 382-385

Abbink, E.J.; Tack, C.J.; Pickkers, P.; Van Rosendaal, A.J.; Smits, P. 2000: Vascular effects of glibenclamide, glimepiride, metformin and acarbose in type 2 DM patients. Diabetologia 43(Suppl 1): A39

Collins, P. 2001: Vascular effects of hormones. Maturitas 38(1): 45-50; Discussion: 50-51

Kuang, W.; Chen, Y.Y.; Shen, Y.L.; Xia, Q. 2004: Vascular effects of iron overload and the underlying mechanism. FASEB Journal 18(4-5): Abstract 699

Blum, A.; Schenke, W.H.; Hathaway, L.; Mincemoyer, R.; Panza, J.A.; Cannon, R.O.IIi 1999: Vascular effects of oral L-arginine therapy in patients with coronary artery disease on conventional medical management. Journal of the American College of Cardiology 33(2 Suppl A): 319A-320A

Kaga, M.; Saitoh, Y.; Honma, Y.; Ishihata, A.; Katano, Y. 2004: Vascular effects of polyphenolic substances in rat aorta. Journal of Pharmacological Sciences 94(Suppl 1): 220P

Omar, H.A. 1999: Vascular effects of progesterone in the human utero-placental circulation. FASEB Journal 13(4 Part 1): A128

Huang, Y.; Lau, C.W.; Chan, F.L.; Yao, X.Q.; Chen, Z.Y.; Wang, Z.T. 2000: Vascular effects of purified alpinetin and cardamonin from Alpinia blepharocalyx. FASEB Journal 14(4): A494

Abebe, W.; Schuster, G.S. 2000: Vascular effects of resin components used in dentistry. FASEB Journal 14(4): A149

Koh, K.K.; Ahn, J.Y.; Shin, M.S.; Han, S.H.; Choi, I.S. 2003: Vascular effects of simvastatin and ramipril in hypercholesterolemic patients. European Heart Journal 24(Abstract Suppl): 345

Yoshino, F.; Lee, C.I.; Todoki, K. 2000: Vascular effects of singlet oxygen on the adrenergic neurotransmission in the isolated rabbit mesenteric vein. Free Radical Biology and Medicine 29(Suppl 1): S96

Varin, R.; Mulder, P.; Richard, V.; Henry, J.P.; Lerebours, G.; Thuillez, C. 2000: Vascular effects of the association of an angiotensin converting enzyme inhibitor with chronic exercise in rats with heart failure. Fundamental and Clinical Pharmacology 14(3): 295

Bhattacharya, A.; Grinnell, B.W.; Cohen, M.L. 2000: Vascular effects of thrombin, trypsin, protein C, activated protein C and thrombomodulin. FASEB Journal 14(4): A681

Togashi, H.; Nakai, K.; Sakuma, I.; Fujii, S.; Kitabatake, A.; Yoshioka, M. 1999: Vascular effects of unmodified hemoglobin and S-nitrosohemoglobin in rats. Japanese Journal of Pharmacology 79(Suppl 1): 183P

Don Michael, T.A.; Besselink, P. 2002: Vascular embolism prevention device employing filters. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)

Greene, G.R.; Rosenbluth, R.F.; Cox, B.J. 2000: Vascular embolization with an expansible implant. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Greff, R.J. 2000: Vascular embolizing compositions comprising ethyl lactate and methods for their use. Official Gazette of the United States Patent and Trademark Office Patents 1233(3)

Gingras, P.; Martakos, P.; Karwoski, T.; Herweck, S.A. 2002: Vascular endoprosthesis and method. Official Gazette of the United States Patent and Trademark Office Patents 1260(4)

Kumagai, A.K.; Sone, H.; Deo, B. 1999: Vascular endothelial GLUT1 overexpression activates multiple signal transduction pathways. Diabetes 48(Suppl 1): A19

Ing, M.H.; Fang, Q.; Navab, M.; Sevanian, A.; Marcu, L.; Hsiai, T.K. 2003: Vascular endothelial NAD H autofluorescence in response to ox-LDL. FASEB Journal 17(4-5): Abstract 575

Spiecker, M.; Rose, M.; Zimmermann, B.; Muegge, A. 2003: Vascular endothelial NF-kappa B inhibition by NO Inhibition of RelA phosphorylation by NO. Circulation 108(17): IV254-IV255

Debieve, F.; Moiset, A.; Hubinont, C.; Pampfer, S.; Thomas, K. 2000: Vascular endothelial and placental growth factors in Downs syndrome and normal pregnancies. Placenta 21(7): A 50

Hsu, C.D.; Pavlik, J.; Harirah, H. 2003: Vascular endothelial apoptosis, injury, and dysfunction in placenta as evidence for the pathogenesis in severe preeclampsia. American Journal of Obstetrics and Gynecology 189(6 Suppl): S93

Lee, M.; Thangada, S.; Claffey, K.; Ancellin, N.; Liu, C.; Hla, T. 2000: Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Journal of Submicroscopic Cytology and Pathology 32(3): 434

Wu, G.D.; Jin, Y.S.; Barr, M.L.; Starnes, V.A.; Cramer, D.V. 2002: Vascular endothelial cell apoptosis induced by non-MHC alloantibodies An important injury mechanism in the development of chronic graft rejection. Journal of Heart and Lung Transplantation 21(1): 72

Poston, L.; Chappell, L. 2000: Vascular endothelial cell dysfunction in pre-eclampsia A role for oxidative stress?. Journal of Physiology (Cambridge) (523P): 43S

Narimatsu, K.; Ogura, T.; Tampo, A. 2004: Vascular endothelial cell function evaluating apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Weingaertner, K.; Kruchten, B.; Heuschmid, M.; Dexler, B.; Riedmiller, H. 1999: Vascular endothelial cell growth factor -immunoreactivity in renal cell carcinoma. Journal of Urology 161(4 Suppl): 148

Bayne, M.L.; Thomas, K.A. 1999: Vascular endothelial cell growth factor C subunit. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Bayne, M.L.; Conn, G.L.; Thomas, K.A. 2001: Vascular endothelial cell growth factor II. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Findeisen, R.; Gerlach, A.; Albrecht, S.; Richter, B.; Zimmermann, T.; Distler, W. 2002: Vascular endothelial cell growth factor in comparison with tissue polypeptide antigen , cancer antigen 15-3 and carcinoembryonic antigen in the follow-up of breast cancer. European Journal of Cancer 38(Suppl 1): S48-S49

Murphy, J.F.; Fitzgerald, D.J. 2000: Vascular endothelial cell growth factor induces cyclooxygenase -2 dependent proliferation of endothelial cells via the VEGF II receptor. Circulation 102(18): 2; 63

Kang, D.H.; Oh, S.W.; Jefferson, J.A.; Schreiner, G.F.; Johnson, R.J. 2000: Vascular endothelial cell growth factor preserves renal function and reduces fibrosis in the 5/6 remnant kidney model. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 508A

Taomoto, M.; Witte, L.; Mcleod, D.S.; Merges, C.A.; Zhu, Z.; Lutty, G.A. 1999: Vascular endothelial cell growth factor receptor-2 in normal retinal vasculogenesis and canine oxygen-induced retinopathy. IOVS Investigative Ophthalmology and Visual Science 40(4): S703

Chen, Z.T.; Backora, M.; Varney, M.L.; Guo, Y.J.; Singh, R.K. 2003: Vascular endothelial cell growth factor-C expression, lymphangiogenesis and immune response in murine malignant melanoma and mammary adenocarcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 44: 406

Jones, Steven P.; Van Haperen, Rien; De Crom, Rini; Kawashima, Seinosuke; Yokoyama, Mitsuhiro; Lefer, David J. 2002: Vascular endothelial cell overexpression of the eNOS gene attenuates the extent of myocardial reperfusion injury. Circulation 106(19): II56-II57

Sata, M.; Walsh, K. 1999: Vascular endothelial cells and smooth muscle cells differ in their expression of Fas and Fas ligand and in their sensitivity to Fas ligand-induced cell death. Circulation 100(18): 1; 485

Kummer, M.; Biedermann, B.C. 2004: Vascular endothelial cells are poor targets of peptide-specific, MHC-restricted cytotoxic T lymphocytes. FASEB Journal 18(4-5): Abstract 277

Brzezinska, A.K.; Chilian, W.M. 2002: Vascular endothelial cells conduct superoxide via CIC-3 chloride channel. Circulation 106(19): II212

O'connell, B.J.; Denis, M.; Genest, J. 2002: Vascular endothelial cells express ABCG1 but not ABCA1 in response to cholesterol loading. Circulation 106(19): II72-II73

Biedermann, B.C.; Pober, J.S. 2000: Vascular endothelial cells regulate lymphocyte growth and differentiation by cell-contact dependent and independent mechanisms. Journal of Submicroscopic Cytology and Pathology 32(3): 351

Chaves, A.A.; Coyle, C.M.; Brady, J.E.; Dech, S.J.; Joshi, M.S.; Schanbacher, B.L.; Basuray, A.; Baliga, R.S.; Koletar, S.L.; Bauer, J.A. 2003: Vascular endothelial effects of a standardized grape product in humans. Pediatric Research 53(4 Part 2): 559A

Chambers, J.C.; Haskard, D.O.; Kooner, J.S. 1999: Vascular endothelial function and oxidant stress mechanisms in patients with Behcets disease. Circulation 100(18): 1; 212

Bhatt, A.J.; Watkins, R.H.; Chess, P.R.; Maniscalco, W.M. 1999: Vascular endothelial growth factor , VEGF receptor and hypoxia inducible factor - like factor mRNA abundance are increased by dexamethasone in postnatal mouse lung. Pediatric Research 45(4 Part 2): 48A

Paulus, P.; Berger, A.; Abraham, D.; Aharinejad, S. 2002: Vascular endothelial growth factor -A165 gene expression correlates with poor prognosis mammary carcinoma. FASEB Journal 16(4): A367

Kawasaki, J.; Hirano, K.; Nishimura, J.; Kanaide, H. 1999: Vascular endothelial growth factor -induced angiogenesis is inhibited by SKF 96365, a Ca2+ influx inhibitor. Japanese Journal of Pharmacology 79(Suppl 1): 167P

Boulday, G.; Reinders, M.E.J.; Flaxenburg, J.A.; Pal, S.; Briscoe, D.M. 2003: Vascular endothelial growth factor -mediated activation of IP-10 expression in endothelial cells involves the PI3-K signaling pathway. Journal of the American Society of Nephrology 14(Abstracts Issue): 12A

Shimizu, A.; Masuda, Y.; Hori, T.; Ohashi, R.; Sugisaki, Y.; Yamanaka, N. 2000: Vascular endothelial growth factor 165 enhances glomerular capillary repair and accelerates the recovery from experimental progressive glomerulonephritis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 499A

Sugiono, M.; Bates, D.O.; Harper, S.; Oxley, J.; Gillatt, D. 2003: Vascular endothelial growth factor 165b, a novel and inhibitory VEGF isoform is down-regulated in prostatic intraepithelial neoplasia and locally advanced prostate cancer. Journal of Urology 169(4 Suppl): 164

Hu, J.S.; Rosen, C.A.; Cao, L. 1999: Vascular endothelial growth factor 2. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)

Sondell, M.; Lundborg, G.; Kanje, M. 1999: Vascular endothelial growth factor ; axonal outgrowth and the expression of the VEGF Receptor FLK-1 in cultured peripheral ganglia. Society for Neuroscience Abstracts 25(1-2): 233

Brockelsby, J.C. 2000: Vascular endothelial growth factor A role in the pathophysiology of pre-eclampsia. Clinical Science 99(2): 7P-8P

Ernhardt, B.; Blohmer, J.U.; Schuerenkaemper, P.; Lichtenegger, W. 2000: Vascular endothelial growth factor A surrogate marker of response in neoadjuvant chemotherapy of breast cancer? Preliminary results of a clinical trial. Breast Cancer Research and Treatment 64(1): 131

Hammam, O.; El Baz, H.; El Baz, A. 2003: Vascular endothelial growth factor An important angiogenic mediator in chronic urinary bladder lesions. Virchows Archiv 443(3): 431

Ferrara, N. 2004: Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25(4): 581-611

Alitalo, K.; Joukov, V. 2000: Vascular endothelial growth factor C DELTACys156 protein and gene, and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1239(2)

Karamysheva, A.; Shushanov, S.; Bronstein, M.; Shatalova, L.; Stavrovskaya, A.; Martinova, E. 1999: Vascular endothelial growth factor C and its receptor FLT4 expression in human thyroid pathology. Journal of Investigative Medicine 47(4): 195A

Alitalo, K.; Joukov, V. 2004: Vascular endothelial growth factor C protein and gene mutants thereof, and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1288(3)

Hagen, D.B.; Bauerfeind, I.; Konecny, G.; Kahlert, S.; Nestle Kraemling, C.; Boettcher, B.; Untch, M. 2000: Vascular endothelial growth factor Cytosol levels in primary breast cancer and correlation to established prognostic factors. Breast Cancer Research and Treatment 64(1): 132

Hayashi, T.; Itoyama, Y.; Abe, K. 2001: Vascular endothelial growth factor Protection against ischemic brain damage with MCA occlusion in rats. Fukuuchi, Y , Tomita, M , Koto, A Keio University Symposia for Life Science and Medicine Ischemic blood flow in the brain 120-127

Pecoits Filho, R.F.S.; Araujo, M.R.gina T.; Lindholm, B.; Abensur, H.; Numata, M.; Noronha, I.L. 2001: Vascular endothelial growth factor Relationship to inflammation and peritoneal solute transport rate in peritoneal dialysis patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 438A

Downey, S.; Adams, J.; Lansdown, M.; Brennan, T.G.; Perren, T.; Forbes, M.A.; Carder, P.; Maclennan, K.; Selby, P.; Banks, R. 1999: Vascular endothelial growth factor Serum and plasma levels in breast cancer patients. Breast Cancer Research and Treatment 57(1): 92

Farahani, M.; Treweeke, A.; Toh, C.H.; Zuzel, M.; Chen, H.J. 2003: Vascular endothelial growth factor activates nuclear factor kappaB in chronic lymphocytic leukaemia cells. British Journal of Haematology 121(Suppl 1): 11

Barr, M.P.; Bouchier Hayes, D.J.; Harmey, J.H. 2002: Vascular endothelial growth factor acts as a tumor cell survival factor under hypoxia. Proceedings of the American Association for Cancer Research Annual Meeting 43: 329-330

Koellermann, J.W.; Helpap, B. 2002: Vascular endothelial growth factor and VEGF receptor 1 in malignant and nonmalignant prostate tissue. Journal of Urology 167(4 Suppl): 137

Otani, A.; Takagi, H.; Oh, H.; Koyama, S.; Sugita, G.; Ogura, Y. 2003: Vascular endothelial growth factor and angiopoietin 2 expression in laser-treated choroidal neovascular membranes. Retina 23(3): 402-404

Park, S.K.; Hwang, J.M.; Kim, W.; Ha, H.; Koh, G.Y. 1999: Vascular endothelial growth factor and angiopoietin-1 are strong mesangial cell survival factors. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 498A-499A

Bove, K.; Wood, P.A.; Hrushesky, W.J.M. 1999: Vascular endothelial growth factor and basic fibroblast growth factor gene expression and breast cancer outcome vary with fertility cycle stage. Proceedings of the American Association for Cancer Research Annual Meeting 40: 453

Weber, F.; Sepp, N.; Fritsch, P. 2000: Vascular endothelial growth factor and basic fibroblast growth factor in melanoma. British Journal of Dermatology 142(2): 392-393

Dudek, A.Z.; Mahaseth, H. 2002: Vascular endothelial growth factor and basic fibroblast growth factor levels change after chemotherapy in non-small cell lung cancer patients Correlation with tumor response, number of platelets, and leucocytes. Proceedings of the American Association for Cancer Research Annual Meeting 43: 894

Galley, H.F.; Macleod, S.; Banks, R.; Webster, N.R. 1999: Vascular endothelial growth factor and bioimpedance in critically ill patients. British Journal of Anaesthesia 83(1): 169P

Nam, D.H.; Park, K.; Kim, J.H. 2001: Vascular endothelial growth factor and brain specific angiogenesis inhibitor-1 expression in glioblastomas A relation to prognosis. Proceedings of the American Association for Cancer Research Annual Meeting 42: 650

Gudehithlu, K.P.; Singh, A.K. 1999: Vascular endothelial growth factor and diabetic nephropathy. International Journal of Artificial Organs 22(5): 297-299

Wakabayashi, T.; Takayama, M.; Shinoda, K.; Ishida, S.; Kawashima, S.; Yamada, M. 1999: Vascular endothelial growth factor and hepatocyte growth factor in the intraocular fluid in the patients with diabetes mellitus. IOVS Investigative Ophthalmology and Visual Science 40(4): S703

Coradini, D.; Costa, A.; Lagonigro, S.; Pellizzaro, C.; Daidone, M.G.azia 2000: Vascular endothelial growth factor and hypoxia-inducible factor-1 in primary and metastatic liver lesions. Proceedings of the American Association for Cancer Research Annual Meeting 41: 166

Ekekezie, I.I.; Thibeault, D.W.; Rezaiekhaligh, M.; Norberg, M.; Mabry, S.; Zhang, X.; Truog, W.E. 2002: Vascular endothelial growth factor and its Flk-1 receptor in young piglets lungs Effect of hyperoxia and inhaled nitric oxide. Pediatric Research 51(4 Part 2): 472A-473A

Padro, T.; Steins, M.; Bieker, R.; Buechner, T.; Berdel, W.E.; Mesters, R.M. 2001: Vascular endothelial growth factor and its cellular receptor KDR are overexpressed in the bone marrow of patients with acute myeloid leukemia. Annals of Hematology 80(Suppl 1): A51

Jones, A.; Crew, J. 2000: Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression. Urologic Clinics of North America 27(1): 191-197

Lu, G.; Lin, N.; Grewal, S. 2000: Vascular endothelial growth factor and its receptor 1 are significantly produced in pterygia. IOVS Investigative Ophthalmology and Visual Science 41(4): S451

Koellermann, J.; Helpap, B. 2001: Vascular endothelial growth factor and its receptor Flk-1 in malignant and nonmalignant prostate tissue. Pathology Research and Practice 197(5): 341

Kanellis, J.; Khong, T.F.; Katerelos, M.; Stacker, S.A.; Cox, A.J.; Gilbert, R.E.; Cooper, M.E.; Power, D.A. 2000: Vascular endothelial growth factor and its receptors are up-regulated in passive Heymann nephritis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 491A

Matsubara, O.; Imazeki, N.; Ozeki, Y.; Mark, E.J. 2002: Vascular endothelial growth factor and its receptors, Flt1 and KDR/Flk1, in diffuse alveolar damage and advanced pulmonary fibrosis. Laboratory Investigation 82(1): 324A

Vardhan, A.; Summers, A.; Brenchley, P.; Gokal, R. 2003: Vascular endothelial growth factor and its soluble receptor in patients with dialysis dependent renal failure. Journal of the American Society of Nephrology 14(Abstracts Issue): 220A

Blann, A.D.; Belgore, F.M.; Mccollum, C.N.; Lip, G.Y.H. 2000: Vascular endothelial growth factor and its soluble receptor in peripheral and coronary artery disease. Haemostasis 30(1-2): 60

Ochs, A.G.; Kraft, A.; Berger, E.; Siegerstetter, V.; Blum, H.; Roessle, M. 1999: Vascular endothelial growth factor and liver disease. Gastroenterology 116(4 Part 2): A1257

Reynaert, H.; Chavez, M.; Geerts, A. 2001: Vascular endothelial growth factor and liver regeneration. Journal of Hepatology 34(5): 759-761

Aldona, D.K.; Dulak, J.; Jozkowicz, A.; Guevara, I.; Zdzienicka, A.; Cook, J. 1999: Vascular endothelial growth factor and nitric oxide reciprocal regulation in gene expression and modulation of the vascular cell proliferation. European Journal of Clinical Investigation 29(Suppl 1): 74

Shijubo, N.; Uede, T.; Kon, S.; Nagata, M.; Abe, S. 2000: Vascular endothelial growth factor and osteopontin in tumor biology. Critical Reviews in Oncogenesis 11(2): 135-146

Hyakutake, M.; Saga, T.; Yamaki, K.; Yoshizuka, M. 2003: Vascular endothelial growth factor and parathyroid hormone /PTH-related peptide receptor in the femoral head of the growing rat. Biomedical Research 14(2): 203-210

Schaeffer, R.C. 2000: Vascular endothelial growth factor and placenta growth factor initiate endothelial monolayer hyperpermeability by distinct signaling mechanisms. Molecular Biology of the Cell 11(Suppl): 242a-243a

Rimouche, S.; Lash, G.E.; Strachan, B.K.; Heasman, L.; Cooper, S.; Symonds, M.E.; Baker, P.N. 1999: Vascular endothelial growth factor and placental growth factor and their receptors in the ovine placenta. Journal of Physiology (Cambridge) 517P: 39P

Feeney, S.A.; Simpson, D.A.C.; Gardiner, T.A.; Boyle, C.; Jamison, P.; Archer, D.B.; Stitt, A.W. 2001: Vascular endothelial growth factor and placental growth factor have distinct and critical roles during retinal vascular development and degeneration. IOVS Investigative Ophthalmology and Visual Science 42(4): S90

Masuda, H. 2000: Vascular endothelial growth factor and platelets. Internal Medicine 39(7): 527-528

Mohan, J.; Lip, P.L.; Bareford, D.; Lip, G.Y.; Blann, A.D. 2004: Vascular endothelial growth factor and proliferative retinopathy in sickle cell disease. British Journal of Haematology 125(Suppl 1): 28

Young, H.S.; Summers, A.M.; Bhushan, M.; Brenchley, P.E.C.; Griffiths, C.E.M. 2003: Vascular endothelial growth factor and psoriasis. British Journal of Dermatology 148(4): 852

Assy, N.N.; Kraizer, Y.; Paizi, M.; Baruch, Y.; Dabbach, B.; Spira, G. 1999: Vascular endothelial growth factor and respective monoclonal antibodies can modulate liver cell proliferation following partial hepatectomy in rats. Hepatology 30(4 Part 2): 252A

Belgore, F.M.; Lip, G.Y.H.; Mccollum, C.N.; Blann, A.D. 2000: Vascular endothelial growth factor and soluble Flt-1 in patients with atherosclerotic vascular disease. Clinical Science 99(2): 19P-20P

Chin, B.S.P.; Chung, N.A.Y.; Gibbs, C.R.; Blann, A.D.; Lip, G.Y.H. 2002: Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. American Journal of Cardiology 90(11): 1258-1260

Blann, A.D.; Wadley, M.; Stonelake, P.; Belgore, F.M.; Bareford, D.; Lip, G.Y.H. 2000: Vascular endothelial growth factor and soluble VEGF receptor in haematological cancer. Haemostasis 30(1-2): 16

Belgore, F.; Lip, G.Y.H.; Mccollum, C.N.; Blann, A.D. 1999: Vascular endothelial growth factor and soluble VEGF receptor levels in coronary artery disease and peripheral artery disease. Blood Coagulation and Fibrinolysis 10(8): 536

Cacciola, R.; Di Francesco, E.; Stagno, F.; Giustolisi, R.; Cacciola, E. 2002: Vascular endothelial growth factor and thrombopoietin in myeloid disorders. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 48

Cacciola, R.R.; Di Francesco, E.; Ferlito, C.; Guarnaccia, G.G.; Giustolisi, R.; Cacciola, E. 2003: Vascular endothelial growth factor and thrombopoietin in patients with essential thrombocythemia and polycythemia vera and thrombotic complications. Acta Haematologica 110(4): 202-203

Matsubara, O.; Imazeki, N.; Okochi, Y.; Ozeki, Y.; Mark, E.J. 2001: Vascular endothelial growth factor and thrombospondin-1 in diffuse alveolar damage and advanced pulmonary fibrosis. Laboratory Investigation 81(1): 223A

Ozveren, B.; Turkeri, L.N.; Ozyurek, M. 2000: Vascular endothelial growth factor and thrombospondin-1 mRNA expression correlates with poor prognosis in human transitional cell carcinoma. European Urology 38(4): 516

Makin, A.J.; Chung, N.A.Y.; Silverman, S.H.; Lip, G.Y.H. 2002: Vascular endothelial growth factor and tissue factor in patients with established peripheral vascular syndrome A link between angiogenesis and thrombogenesis?. British Journal of Haematology 117(Suppl 1): 89-90,

Cacciola, E.; Di Francesco, E.; Ferlito, C.; Guarnaccia, G.G.; Giustolisi, R.; Cacciola, R.R. 2003: Vascular endothelial growth factor and tissue factor pathway inhibitor in essential thrombocythemia and polycythemia vera Any interrelation?. Experimental Hematology (New York) 31(7 Suppl 1): 221

Taira, T.; Yoshimura, A.; Inui, K.; Morita, H.; Ideura, T.; Hyodo, T.; Chiba, T.; Hidai, H. 2001: Vascular endothelial growth factor and transforming growth factor-beta are closely associated with angiogenesis of acquired cystic kidney disease -related neoplasm in long-term dialysis patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 413A-414A

Tuttle, R.M.; Patel, A.; Francis, G.; Davis, S.; Kopecky, K.; Lushnikov, E.; Abrosimov, A.; Troshin, V.; Tsyb, A.; Fenton, C. 2000: Vascular endothelial growth factor and type 1 VEGF receptor are highly expressed in Russian papillary thyroid cancers. Endocrine Journal 47(Suppl August): 207

Linderholm, B.; Gruvberger, S.; Ferno, M.; Bendahl, P.O.; Malmstrom, P. 1999: Vascular endothelial growth factor and urokinase plasminogen activator are independent prognostic factors for distant recurrences in premenopausal node-negative breast cancer. Breast Cancer Research and Treatment 57(1): 98

Cipriani, R.; Iacobellis, G.; Gabriele, A.; Bianchi, C.; Pantellini, F.; Di Mario, U.; Morano, S. 2001: Vascular endothelial growth factor and ventricular remodeling in patients with type 2 diabetes and hypertension. Diabetologia 44(Suppl 1): A306

Plavetic, N.D.; Razumovic, J.J.; Vrbanec, D. 2003: Vascular endothelial growth factor as a prognostic indicator in breast carcinoma. Breast 12(Suppl 1): S26

Gordon, M.S. 2000: Vascular endothelial growth factor as a target for antiangiogenic therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(21 Suppl): 45s-46s

Bellamy, W.T. 2002: Vascular endothelial growth factor as a target opportunity in hematological malignancies. Current Opinion in Oncology 14(6): 649-656

Steiner, H.; Berger, P.A.; Godoy Tundidor, S.; Bjartell, A.; Lilja, H.; Bartsch, G.; Hobisch, A.; Culig, Z. 2004: Vascular endothelial growth factor autocrine loop in prostate cancer cells generated after prolonged treatment with interleukin-6. European Urology Suppls 3(2): 92

D.B., F.G.; Sandri, M.T.; Zorzino, L.; Locatelli, M.; Masci, G.; Rocca, A.; Luca, F.; Zamping, G. 2000: Vascular endothelial growth factor blood levels of patient with advanced solid tumors treated with chemotherapy are not related to treatment response. Proceedings of the American Association for Cancer Research Annual Meeting 41: 308

Schmidt Lucke, C.; Reinhold, D.; Mlasowsky, B.; Kollmann, A.; Prinzen, M.; Ansorge, S.; Klein, H.U.; Schmidt Lucke, J.A. 2000: Vascular endothelial growth factor but not soluble vascular cell adhesion molecule-I serves as a biohumoral correlate of endothelial dysfunction in smokers. European Heart Journal 21(Abstract Suppl): 635

Youssif, M.; Shiina, H.; Shirai, M.; Gleason, C.; Nunes, L.N.; Igawa, M.; Dahiya, R.; Tanagho, E.A. 2003: Vascular endothelial growth factor can regenerate bladder acellular matrix graft Histologic and functional evaluation. Journal of Urology 169(4 Suppl): 47

Grover, T.R.; Zenge, J.P.; Parker, T.A.; Abman, S.H. 2002: Vascular endothelial growth factor causes pulmonary vasodilation through activation of the PI3-kinase- nitric oxide pathway in the late gestation ovine fetus. Pediatric Research 51(4 Part 2): 389A

Bates, D.O. 2000: Vascular endothelial growth factor chronically increases microvascular diameter and distensibility, but not hydraulic conductivity , through phosphorylation of map kinase. Journal of Vascular Research 37(Suppl 1): 12

Nishizawa, K.; Kadonosono, K.; Itoh, N.; Matsumoto, S.; Shinbo, M.; Ohno, S. 1999: Vascular endothelial growth factor concentration in posterior vitreous precortical pocket in proliferative diabetic retinopathy. IOVS Investigative Ophthalmology and Visual Science 40(4): S703

Haggstrom, S.; Bergh, A.; Damber, J.E. 1999: Vascular endothelial growth factor content in metastasizing and non metastasizing dunning prostatic adenocarcinomas. European Urology 36(5): 483

Reinders, M.E.J.; Sho, M.; Geehan, C.; Briscoe, D.M. 2001: Vascular endothelial growth factor contributes to the recruitment of inflammatory cells by inducing the chemokines MCP-1 and IP-10. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 865A

Duraisamy, S.; Faulkner, J.L.; Abboud, H.E.; Choudhury, G.G.; Kasinath, B.S. 2001: Vascular endothelial growth factor control of protein synthesis and regulation of VEGF system by angiotensin II in proximal tubular epithelial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 566A-567A

Eve, B.; Sweeney, P.; Bielenberg, D.; Killion, J.J.; Kim, S.J.; Rosenblum, M.; Waltenberger, J.; Bar Eli, M.; Mcconkey, D.; Dinney, C.P. 2003: Vascular endothelial growth factor directly modulates matrix metalloproteinase-9 expression by human bladder cancer through neuropilin receptor activation. Journal of Urology 169(4 Suppl): 196

Dikov, M.M.; Oyama, T.; Nadaf, S.; Gabrilovich, D.I.; Carbone, D.P. 2001: Vascular endothelial growth factor effects on NF-kappaB activation in hematopoietic progenitor cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 958-959

Amemiya, T.; Sasamura, H.; Mifune, M.; Nakaya, H.; Hayashi, M.; Saruta, T. 1999: Vascular endothelial growth factor enhances collagen synthesis in human mesangial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 567A

Syed, F.; Brenchley, P.E.C.; Roberts, I.S.D. 1999: Vascular endothelial growth factor expression and angiogenesis in atherosclerosis. Journal of Pathology 189(Suppl): 11A

Takahashi, R.; Tanaka, S.; Kitadai, Y.; Sanomura, M.; Tamura, T.; Tanaka, T.; Morihara, M.; Sumii, M.; Yoshihara, M.; Haruma, K.; Chayama, K. 2002: Vascular endothelial growth factor expression and angiogenesis in gastrointestinal stromal tumor of stomach. Gastroenterology 122(4 Suppl 1): A 598

Clopton, D.T.; Toombs, C.F.; Cupp, A.S. 2001: Vascular endothelial growth factor expression and localization indicates role in testis morphogenesis and Sertoli-germ cell interactions during embryonic testis development. Biology of Reproduction 64(Suppl 1): 209-210

Sims, H.; Nickols, C.D.; Feakins, R.M. 2003: Vascular endothelial growth factor expression and microvascular density in gastrointestinal stromal tumours. Journal of Pathology 201(Suppl): 17A

de Queiroz, G.Fernandes.; Dagli, M.Lucia.Zaidan.; Fukumasu, H.; Zavala, A.Alejandro.Zavala.; Matera, J.Maria. 2010: Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 22(1): 105-108

Cetin, S.E.; Ozbilim, G.; Guney, K.; Karakaya, S. 2003: Vascular endothelial growth factor expression and microvessel count in laryngeal squamous cell carcinoma. Virchows Archiv 443(3): 344-345

Granato, A.M.; De Paola, F.; Medri, L.; Dubini, A.; Sarti, M.; Vecci, A.M.; Amadori, D.; Volpi, A. 2000: Vascular endothelial growth factor expression and microvessel density in human breast cancer. International Journal of Biological Markers 15(3): 265

Rowe, D.H.; Kayton, M.L.; Marboe, C.C.; Kandel, J.J.; Stolar, C.J. 1999: Vascular endothelial growth factor expression and pulmonary development in murine fetal heart-lung culture. Pediatric Research 45(4 Part 2): 60A

Angelov, L.; Salhia, B.; Roncari, L.; Mcmahon, G.; Shawver, L.; Powell, J.; Guha, A. 1999: Vascular endothelial growth factor expression and receptor inhibition in human peripheral nerve tumors. Proceedings of the American Association for Cancer Research Annual Meeting 40: 228

Singh, M.; Marks, J.L.; Nawaz, S.; Finlayson, C.A.; Seilgman, P.A. 2001: Vascular endothelial growth factor expression before and after neoadjuvant chemotherapy in locally advanced breast carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 42: 8

Higgins, G.T.; Wang, J.H.; Cleary, P.; Redmond, H.P. 2000: Vascular endothelial growth factor expression by a retinal pigment epithelial cell line is down-regulated by UVB in normoxia, but up-regulated in hypoxia. IOVS Investigative Ophthalmology and Visual Science 41(4): S838

Donovan Peluso, M.; Burholt, D.; Rosenblum, E.; Hassett, A.C.; Kornblith, P. 2000: Vascular endothelial growth factor expression by cultured ovarian tumor cells correlates with chemotherapeutic cytotoxity. Proceedings of the American Association for Cancer Research Annual Meeting 41: 165

Andonian, S.; Dam, V.; Begin, L.; Chevalier, S.; Aprikian, A.G. 2001: Vascular endothelial growth factor expression from neuroendocrine cells is associated with invasive phenotype and pathologic stage rather than microvessel density in prostate cancer. Journal of Andrology (Suppl): 150

Schnurrbusch, U.; Goelfert, F.; Fehrenbach, H.; Hoffmann, S.; Funk, R.H.W.; Wolf, S.; Wiedemann, P. 2000: Vascular endothelial growth factor expression in active and fibrotic choroidal neovascular membranes. IOVS Investigative Ophthalmology and Visual Science 41(4): S835

Hunter, G.C.; Burke, A.S.; Xue, X.Y.; Lick, S.D.; Cox, R.A.; Hawkins, H.K. 2001: Vascular endothelial growth factor expression in atherosclerotic plaque and arterialized vein grafts. FASEB Journal 15(5): A950

Garcia, F.U.; Liu, C.; Nicosia, R.F.; Hou, J.S.; Zhang, S.; Hazelton, D. 1999: Vascular endothelial growth factor expression in benign prostatic hyperplasia , atrophy, PIN and carcinoma. Modern Pathology 12(1): 95A

Hughes, L.A.; Heydon, K.; Edmonds, P.; Roach, M.; Wolkov, H.; Shah, S.; Pollack, A.; Hammond, M.; Dicker, A.P. 2003: Vascular endothelial growth factor expression in locally advanced prostate cancer Secondary analysis of radiation therapy oncology group 8610. International Journal of Radiation Oncology Biology Physics 57(2 Suppl): S201-S202

Bortoloso, E.; Del Prete, D.; Anglani, F.; Fioretto, P.; Gambaro, G.; Baggio, B.; Antonucci, F.; Nosadini, R.; Crepaldi, G. 1999: Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. Diabetologia 42(Suppl 1): A273

Oh, M.J.; Jeong, U.A.; Kim, H.J.; Kim, I.S. 2003: Vascular endothelial growth factor expression in myometrial resistance arteries in women with preeclampsia. American Journal of Obstetrics and Gynecology 189(6 Suppl): S93

Zhang, S.L.; Quddus, M.R.; Steinhoff, M.M.; Sung, C.J. 2000: Vascular endothelial growth factor expression in normal endocervical epithelium Cervical adenocarcinoma in-situ, and invasive adenocarcinoma of cervix. Laboratory Investigation 80(1): 135A

Brodmann, M.; Renner, W.; Stark, G.; Seinost, G.; Pilger, E. 2001: Vascular endothelial growth factor expression in patients suffering from thrombangitis obliterans. International Journal of Cardiology 80(2-3): 185-186

Oh, M.J.; Ryu, H.M.; Shin, J.C.; Popek, E.J. 2001: Vascular endothelial growth factor expression in placentae from pregnancies complicated by preeclampsia. American Journal of Obstetrics and Gynecology 185(6 Suppl): S172

Cha, D.R.; Han, S.Y.; Ji, Y.H.; Kang, Y.S.; Lee, S.Y.; Kim, S.W.; Shin, J.H.; Kwon, Y.J.; Cho, W.Y.; Pyo, H.J.; Kim, H.K.; Kang, S.W.; Han, D.S. 2002: Vascular endothelial growth factor expression in response to angiotensin II and angiotensin II receptor antagonist, tumor necrosis factor-alpha and dexamethasone in cultured mouse podocyte. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 497A

Brustmann, H.; Naude, S. 2001: Vascular endothelial growth factor expression in serous ovarian carcinoma Relationship with mitotic activity and FIGO stage. Laboratory Investigation 81(1): 133A

Shapiro, E.; Huang, H.Y.; Levine, A.C.; Walden, P.D.; Wu, X.R. 2000: Vascular endothelial growth factor expression in the human fetal prostate. Journal of Urology 163(4 Suppl): 206

Paradis, V.; Eschwege, P.; Blanchet, P.; Ba, N.; Benoit, G.; Jardin, A.; Bedossa, P. 1999: Vascular endothelial growth factor expression is a prognostic factor in renal cell carcinomas. Modern Pathology 12(1): 103A

Choi, Y.J.; Yang, C.W.; Ahn, H.J.; Kim, Y.S.; Kim, B.K.; Shim, S.I.; Bang, B.K. 2000: Vascular endothelial growth factor expression is differentially regulated in rat kidney with ischemia/reperfusion injury. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 588A

D.B.er, R.A.; Van Veldhuisen, D.J.; Henning, R.H.; Tio, R.A.; Van Gilst, W.H.; Crijns, H.J.G.M. 1999: Vascular endothelial growth factor expression is down-regulated in human chronic heart failure. European Heart Journal 20(ABSTR Suppl ): 12

Burchardt, M.; Burchardt, T.; Hayek, O.; Knight, C.; De La Taille, A.; Shabsigh, A.; Olsson, C.; Buttyan, R. 1999: Vascular endothelial growth factor expression is not affected by castration in the rat ventral prostate. European Urology 36(5): 536